MECHANISMS UNDERLYING NEONATAL CD8+ T CELL DEVELOPMENT AND RESPONSES by Wang, Jie
  
 
MECHANISMS UNDERLYING NEONATAL CD8+ T CELL DEVELOPMENT AND 
RESPONSES 
 
 
 
 
 
 
 
 
A Dissertation 
Presented to the Faculty of the Graduate School 
of Cornell University 
In Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy 
 
 
 
 
 
by 
Jie Wang 
December 2017
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2017 Jie Wang 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
MECHANISMS UNDERLYING NEONATAL CD8+ T CELL DEVELOPMENT AND 
RESPONSES 
Jie Wang, Ph.D. 
Cornell University 2017 
Neonatal infection is a major cause of morbidity and mortality worldwide. While 
adults generate robust immunity to most intracellular pathogens, neonates have an 
impaired ability to generate long-lasting immunity. As CD8+ T cells are essential for 
clearing intracellular pathogens, it is crucial to understand why these cells behave 
differently during infection in early life.  
We previously showed that neonatal CD8+ T cells rapidly become terminally 
differentiated and fail to form long-term memory following infection. However, the 
underlying basis for these age-related differences is unclear. In this thesis, experiments 
were designed to investigate how neonatal and adult CD8+ T cells behave differently 
and what underlying mechanisms contribute to these differences. We demonstrated that 
different aged CD8+ T cell progenitors have different gene expression profiles. Different 
aged progenitors also give rise to CD8+ T cells with distinct characteristics in the 
periphery when developed in the same thymic environment. Ectopic expression of the 
developmentally regulated protein Lin28b in adult CD8+ T cells granted them neonate-
like traits. Our data indicate that different aged CD8+ T cells behave differently because 
they have different origins and Lin28b may regulate CD8+ T cell behaviors in early life. 
Neonatal CD8+ T cells also acquire a much more active metabolic profile compared to 
adult CD8+ T cells, which may contribute to their rapid contraction and poor memory 
formation following infection.  
  
 
Extrinsic differences between different aged animals were also studied by 
transferring adult CD8+ T cells into neonatal mice. Neonatal environment was able to 
modify adult CD8+ T cells to become phenotypically and functionally different. Neonatal-
experienced adult CD8+ T cells proliferated more rapidly and formed insufficient 
memory. These findings suggest that in addition to cell-intrinsic factors, extrinsic factors 
may also contribute to age-related differences in CD8+ T cell behaviors.  
In summary, these findings advance our knowledge of neonatal CD8+ T cell 
responses and cast light on potential therapeutic targets early in life, such as Lin28b, 
mTOR and components of metabolic pathways. A more thorough understanding of 
neonatal immune responses is pivotal for combating diseases in neonates and 
improving their wellbeing. 
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CHAPTER ONE 
Introduction 
Cytotoxic CD8+ T Cells 
Thanks to our immune system, most of us are healthy and able to perform daily 
activities in this non-sterile world. One of the important branches of adaptive immunity is 
consisted of cytotoxic CD8+ T cells, also known as killer T cells. As suggested by their 
name, they specialize in defending the hosts by killing infected and cancer cells.  
Like all other immune cells, CD8+ T cells are derived from the hematopoietic 
stem cells (HSCs). HSCs largely reside in the bone marrow, where they give rise to 
common lymphoid progenitors. The common lymphoid progenitors then travel to the 
thymus to differentiate into CD8-CD4- double negative (DN) thymocytes, which will 
undergo 4 stages of differentiation to give rise to CD4+CD8+ double positive (DP) 
thymocytes1.  In order to commit to either CD8 or CD4 single positive (SP) lineage, the 
DP thymocytes need to go through positive and negative selection to eliminate cells that 
bind too weakly or too vigorously to self-ligand, respectively. The SP cells can then 
leave the thymus to go to the periphery.  
Even though there were early graft-rejection experiments in the 1920s implicated 
the identity and function of CD8+ T cells2,3, it wasn’t until later in 1964 that researchers 
showed small lymphocytes constantly recirculating from the thoracic duct4. This piece of 
evidence laid the groundwork for extensive subsequent studies characterizing the traits 
and function of small lymphocytes5–7. Around the same time, the concept of two 
lymphocytes subsets (B and T) that matured from different origins (bone marrow and 
thymus) was also proposed8–10.  
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In the 1970s, cellular and humoral immunities were proven to be two distinct 
immune responses mediated largely by T and B cells, respectively. By 1975, 
researchers depleted CD8 expressing cells and found that the cellular immunity 
(cytotoxicity) was eliminated, which allowed them to distinguish between CD8+ and 
CD4+ T cells were distinguished based on their phenotypes and functions11–13. Soon 
after that, the protein and genetic compositions of T cell receptors (TCR) were identified 
by several groups14–19, which facilitated the field to better understand how T cells 
recognize antigens and elicit subsequent signaling to perform killing.  
As of today, with all of the pioneering work, we have a better understanding of 
how cytotoxic CD8+ T cells perform their jobs. However, there are still many knowledge 
gaps in CD8+ T cell biology. Therefore, extensive studies are in action to address the 
open questions in the field and advance our knowledge on CD8+ T cells.  
CD8+ T Cell Responses 
Upon infection, dendritic cells (DC) will present infectious agents to CD8+ T cells 
in lymph nodes (LN) to induce activation (priming)20,21. Once activated, CD8+ T cells 
expand to form effector cells, which are consist of functionally and phenotypically 
distinct cell populations. Short-lived effector cells (SLECs) and memory precursor 
effector cells (MPECs) are the two major groups of effector cells that have been well-
characterized22,23. SLECs and MPECs can be distinguished based on their expression 
of different surface markers. SLECs express high levels of killer-cell lectin-like receptor 
G1 (KLRG1) and low levels of IL-7 receptor α (CD127), whereas MPECs express low 
level of KLRG1 but high level of CD12722,23. SLECs are more terminally differentiated 
and are eliminated once infections are cleared, however, MPECs are less terminally 
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differentiated and have the potential to differentiate into long-lived memory cells23,24.  
Activated CD8+ T cells migrate to sites of infection via lymph and blood by 
upregulating expression of chemokine receptors and adhesion molecules25. It is still 
controversial whether activated CD8+ T cells follow a Brownian motion-like (random) or 
a non-Brownian motion-like behavior to detect infected target cells. However, once 
CD8+ T cells bind to the peptide-MHC-I complex on target cells, they can induce 
apoptosis in infected cells by releasing perforin, granzymes and/or upregulating FasL 
(CD95L)26. CD8+ T cells can also perform their cytotoxic functions by producing IFNγ 
and TNFa to activate other effector cells (macrophages and neutrophils) to eliminate 
pathogens via their microbicidal activities27. Once CD8+ T cells clear the infections, 
effector CD8+ T cells will contract to form memory cells, which are responsible for rapid 
secondary responses to combat repeated infections. Thus, CD8+ T cells protect against 
the infections by differentiating into effector cells and convey long-term protection via 
memory formation.  
CD8+ T Cell Memory 
One of the main characteristics of the adaptive immune system is its ability to 
form “immunological memory”. Efficient memory cells are capable of maintaining their 
homeostasis with slow division and acquiring effector function rapidly in response to re-
infection. Memory cells generated after experiencing antigens are commonly known as 
“true memory” cells. True memory CD8+ T cells can be further divided into 3 major 
types: central memory (TCM), effector memory (TEM) and a newly identified subset 
tissue-resident memory T cells (Trm). TCM cells and TEM cells can be distinguished based 
on the expression of molecules such as the chemokine receptor CCR7 and the 
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lymphoid homing marker CD62L. TCM cells express both markers whereas TEM cells lack 
both markers because those molecules promote entry to lymphoid organs28. TCM cells 
largely circulate within lymphoid organs (lymph nodes, spleen and blood), and TEM cells 
mainly circulate among non-lymphoid organs such as liver, lung and intestines28. 
Whereas both TCM and TEM cells have the ability to circulate among organs, Trm cells are 
confined to specific tissue without circulating (ex. mucosal layers). Because they are not 
detectable in blood, Trm cells were identified and characterized later than TCM and TEM 
cells. Trm cells normally resides at tissues prone to infections, thus they can respond to 
local infection immediately and produce progenies that are capable of migrating to other 
sites of infection29.  
Naïve CD8+ T cells can also acquire memory phenotype and characteristics 
without experiencing antigens. Those cells are known as “innate memory T cells” 
reflecting their responses to internal rather than external environments like the “true 
memory” cells. Currently, innate memory cells can be grouped into two subsets: 
lymphopenia-induced and IL-4 induced memory cells.  
Lymphopenia-induced memory cells were identified when proliferation and 
phenotypic changes were observed in naïve T cells that were transferred into 
lymphopenic hosts30. Lymphopenia-induced memory cells share many characteristics 
with true memory cells including phenotypic markers to genetic profiles. However, there 
are still some markers that can be used to distinguish between the two. One of the well-
accepted markers is CD49d (α4-integrin), which is highly expressed on true memory 
cells but low on lymphopenia-induced memory cells30.   
 Certain cytokines have been shown to be important in forming and maintaining 
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lymphopenia-induced memory cells. IL-7, a cytokine known to be essential for T cell 
homeostasis, is also critical for the formation and survival of lymphopenia-induced 
memory T cells. IL-15 has also been shown to be important in maintaining lymphopenia-
induced memory T cells30. CD4+ T cells are more complicated as they can still 
proliferate in lymphopenic environment yet they fail to acquire memory phenotypes and 
sufficient effector traits31.  
IL-4 induced memory cells are generated by exposing to exogenous IL4 
produced by natural killer T (NKT) cells30. IL-4 induced memory cells are first generated 
in thymus when single positive (CD8+CD4- or CD8-CD4+) thymocytes are exposed to 
IL-430. The cells can also be detected in the periphery at steady state in mice. Larger 
proportion of CD8+ IL-4 induced memory cells been observed than CD4+ IL4 induced 
memory cells30. CD8+ IL-4 induced memory cells express the transcription factor 
Eomes, which is different than lymphopenia- and antigen-induced memory cells 
(express Tbet)30.  
Hematopoietic Stem Cells During Development 
As discussed briefly in part 1, like all other immune cells, CD8+ T cells are 
derived from HSCs, which largely reside in the bone marrow in adults. However, there is 
substantial evidence suggesting that distinctive waves of hematopoiesis occur during 
different developmental stages of life32,33. In mammals, the first wave of hematopoiesis 
is more primitive and produces limited blood cell lineages, such as macrophages34. This 
initial wave results from the yolk sac and is HSC-independent32–34. A more definitive 
wave arises later in development and is HSC-dependent32–34. The earliest HSCs were 
identified in aorta-gonad-mesonephros (AGM)32–34. Soon after that, hematopoiesis will 
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migrate to placenta and fetal liver. And then starts in spleens subsequently. 
Hematopoiesis will eventually shift to bone marrow shortly before birth in mammals32–34.  
Not all HSCs that arise throughout fetal life are the same, as evidence suggests 
that there is heterogeneity among HSCs35. With serial transplantation and cell sorting 
experiments, several groups have attempted to group HSC subtypes based on their 
proliferation patterns, self-renewal ability and differential contributions to blood cell 
lineages35,36. The factors segregating HSCs into their subtypes are complex and 
multifactorial. Among all of the potential factors, strong developmental-linked correlation 
has been identified, which can be at least partially explained by differences in 
microenvironments throughout development32. At least in mice, young and aged mice 
tend to have different subtypes of HSCs37–39. Young adult mice have a large amount of 
HSCs with similar preferences to give rise to lymphoid and myeloid cell lineages37–39. 
On the other hand, aged adults have more HSCs preferentially give rise to myeloid cell 
lineage37–39.   
On the other end of the spectrum, fetal/early life HSCs also appear to be quite 
different than adult HSCs. Unlike mostly quiescent adult bone marrow HSCs, HSCs 
isolated from fetal livers have been shown to be highly proliferative and are more 
capable of self-renewal40–42. Interestingly, there is evidence suggesting that fetal liver 
HSCs preferably support their proliferation with energy-generating oxidative metabolic 
pathways, such as oxidative phosphorylation (OXPHOS) and TCA cycle43. This could 
be potentially driven by larger mitochondria in fetal liver HSCs43.  
In addition to differences in proliferation, the progeny of fetal and adult HSCs are 
also different, and these changes happen around the time when hematopoiesis 
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relocates from fetal liver to bone marrow. Among fetal liver HSCs, the majority of them 
are myeloid-lymphoid balanced HSCs with comparable productions of myeloid and 
lymphoid cells44. The proportion of the HSCs preferentially give rise to myeloid lineage 
significantly increases after birth44. As mentioned above the lymphoid-deficient HSCs 
dramatically increases, resulting in the development of more myeloid cells.  
Layered Immune System 
As discussed above, HSCs that arise at different developmental stages have 
different characteristics. The next question is whether these HSCs give rise to same or 
different immune cells in the periphery. Multiple studies have shown that fetal-derived B 
cells demonstrate different traits than adult-derived B cells. B-1 and B-2 are the two 
major populations of B cells. B-1 B cells are known to participate in innate immune 
responses, whereas B-2 B cells are more involved in adaptive responses45. B-1 B cells 
respond rapidly in a B cell receptor (BCR)-independent manner, and these cells 
demonstrate a dampened responsiveness to BCR cross-linking46–49.  
There has been extensive debate regarding the origins of B-1 and B-2 B cells for 
a long time. The two most popular hypotheses are that a) differentiation of B-1 and B-2 
B cells are dependent on specific pathogens and b) B-1 and B-2 B cells develop 
independently and originate from distinct progenitors (layered immune system)50. Over 
the years, extensive evidence has accumulated to support the idea of a layered immune 
system. Experiments transplanting fetal liver and adult bone marrow cells into irradiate 
recipients have shown that fetal progenitors can give rise to both B-1 and B-2 B cells, 
yet adult progenitor are unable to produce B-1 B cells efficiently50. These experiments 
suggest that there are different origins for these different subsets of B cells. Murine fetal 
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B-1 B cell progenitors were later identified with phenotype: lineage negative (Lin-) 
CD93+CD45R-/loCD19+51. Few years later, human B-1 B cell progenitors were also 
identified, further supporting layered immune system52. 
Similar phenomena have been observed with T cells, as evidence has shown 
that fetal HSCs give rise to certain type of T cells53. Both human and murine neonatal 
CD4+ T cells display a Th2 biased response upon activation, which could be attributed 
to the fact that they are derived from a different set of progenitors54–56. In mice, neonatal 
CD4+ T cells produce large amount of Th2 cytokines IL-4 and IL-13 upon activation56,57. 
Neonatal CD4+ T cells still possessed strong Th2 responses following stimulation by 
adult antigen presenting cells (APCs) or transplantation into adult recipients, suggesting 
that the observed differences are likely due to intrinsic differences between adult and 
neonatal CD4+ T cells56,58,59.  
Recently, we demonstrated that different aged progenitors give rise to distinct 
CD8+ T cells in the periphery60. We showed that fetal progenitors (CD4-CD8- 
thymocytes) give rise to CD8+ T cells with unique behaviors in the periphery60. CD8+ 
thymocytes isolated from different aged animals demonstrate different genetic profiles60. 
Neonatal CD8+ thymocytes demonstrate a more effector like genetic profile than their 
adult counterparts60. Fetal thymocytes give rise to mostly memory phenotype naïve 
CD8+ T cells in the peripheral and fail to form sufficient immunological memories post 
infection60. They are also skewed to form SLECs post-infection60.  
Different aged animals also have recent thymic emigrants (RTEs) that are 
functionally and phenotypically different61,62. RTEs, as their name suggests, are the 
newest T cells that enter the periphery from thymus. The cells demonstrate distinct 
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characteristics compared to more mature peripheral T cells. It takes about 3 weeks for 
RTEs to transit into more mature naïve T cells in the periphery61. During this process, 
RTEs will downregulate markers such as CD24 and PD-1, and upregulate markers 
including Qa2 and CD45RB61. RTEs are also functionally different than more mature T 
cells. RTEs are capable of responding to IL-7 without other stimuli but are less 
immunocompetent61. In neonates, it is not surprising that most peripheral CD4+ T cells 
are RTEs. However, neonatal CD4+ RTEs are phenotypically and functionally different 
than adult CD4+ RTEs, providing more evidence of layered immune responses62. 
Neonatal CD4+ RTEs express higher CD24, CD3, and CD28 and lower Qa2 than adult 
CD4+ RTEs62. Upon activation, neonatal CD4+ RTEs also produce higher levels of the 
cytokines IL-4, IL-2 and IFNγ than adult CD4+ RTEs62. Neonatal CD4+ RTEs also 
proliferate more rapidly than adults in response to IL-762. Similar to CD4+ RTEs, 
neonates also have a large percentage of CD8+ RTEs in the periphery. Whereas there 
is no direct comparison between adult and neonatal CD8+ RTEs yet, similar with bulk 
neonatal CD8+ T cells, CD8+ RTEs preferentially differentiate into SLECs as compared 
with mature CD8+ T cells61. However, the differences observed between different aged 
RTEs are not solely due to intrinsic differences in their progenitors, as it is likely that the 
lymphopenic peripheral environment in neonates also contribute to RTEs behaviors62.  
Thus, there is a substantial amount of evidence in supporting the idea that 
immune system does not develop in a linear fashion. Alternatively, existing evidence 
suggests that the immune system consist of different layers that arise at different 
developmental stages. It is likely that both intrinsic and extrinsic factors contribute to the 
differences observed among all the layers.  
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CD8+ T cell Metabolism 
Cellular metabolism plays an important role in supporting cellular functions, 
survival, proliferation and differentiation. In the past decade, extensive studies have 
investigated the contribution of metabolic programs in regulating CD8+ T cell 
responses. As such, six metabolic pathways have been extensively studied in respect to 
CD8+ T cell behavior, including glycolysis, oxidative phosphorylation (OXPHOS), fatty 
acid oxidation, fatty acid synthesis, pentose phosphate and amino acid metabolism63–65 
(Figure 1).  
Glycolysis is a glucose metabolism pathway that converts extracellular glucoses 
to lactic acid. In non-proliferating, differentiated tissues, when there is sufficient oxygen 
availability, glucose metabolism is carried out via OXPHOS and the TCA cycle to 
produce more ATP (up to 36 ATPs)66,67. When oxygen levels are scarce, glucose is 
metabolized through glycolysis and results in lactic acid production in the cytosol66,67. 
However, in heavily proliferating tissues (ex. tumors), glucose is always metabolized 
through glycolysis. This phenomenon is known as the Warburg effect66,67. While this 
catabolic pathway is inefficient at producing energy (generates 2 ATPs), it generates 
many building blocks and cofactors to support the generation of new daughter cells. 
Hence, glycolysis is the preferential pathway used by activated T cells68.  
OXPHOS is used as the predominant ATP producing pathway by naïve cells 
when oxygen is abundant. This pathway occurs in mitochondria when electron transfer 
chain (ETC) couples oxygen consumption with ATP production, driven by NADH and 
FADH2 produced by the TCA cycle64,65. The ETC is composed of 5 complexes including 
ATP synthase, also known as complex V, and other complexes (I, II, III and IV) that are 
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responsible for transporting electrons. Complexes I and II oxidize NADH and FADH2 to 
transfer electrons to complexes III and IV via Coenzyme Q and cytochrome c. 
Throughout the transferring process, protons are constantly pumped through the 
mitochondrial inner member to create a gradient, which can be used to drive ATP 
production by complex V. Because of its extraordinary ATP production, OXPHOS is the 
major pathway utilized by quiescent T cells (naïve and memory) to support their 
homeostatic activities68.  
Fatty acids are the major components of membranes for organelles and cells, 
thus they are important building blocks utilized by proliferating or growing cells64,65. Fatty 
acid synthesis generates fatty acids using metabolites from cellular metabolic pathways 
(ex. glycolysis, TCA cycle and pentose phosphate pathway). Fatty acid synthesis is 
often utilized by activated T cells64,65. 
Fatty acid oxidation (FAO, beta oxidation) is the fatty acid metabolism pathway. 
FAO produces acetyl-CoA, which can feed into the TCA cycle and result in more ATP 
via OXPHOS64,65. FAO also produces its own NADH and FADH2, which can be utilized 
by the ETC to produce ATP. Quiescent memory T cells prefer to use this efficient ATP 
producing pathway over glycolysis64,65,68.    
Activated T cells also utilize Pentose phosphate pathway (PPP) and amino acid 
metabolic pathways. PPP uses glucose-6-P produced by glycolysis to generate 
nucleotides and amino acid precursors64,65. This pathway also generates NADPH, which 
can be used in fatty acid synthesis and is important in maintaining redox 
homeostasis64,65. Amino acids are fundamental building units that can be used by 
several metabolic pathways in cells. Since amino acids are largely used to construct 
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proteins, they involve heavily in anabolic pathways64,65. Hence, just like PPP, amino 
acids metabolism is also very active in actively proliferating cells64,65.  
Metabolic programs involved in CD8+ T cell responses are crucial and complex. 
Depending on the specific metabolic program and demands of the cell, energy is 
created and distributed differently. Since the layered immune response model suggest 
that it will be important to investigate if different aged CD8+ T cells utilize different 
metabolic pathways.  
 
Figure 1.1. Six major metabolic pathways in T cells.  
  
Neonatal CD8+ T cell Response 
Many have noticed that young children are constantly sick and are more prone to 
infections. Globally, more than a third of the deaths in young children (less than 5 years 
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old) happen during the neonatal phase (first month of life)69. While morbidity and 
mortality are much reduced in young children due to expanding maternal vaccines, 
better pre-natal care and advance in medical care. Neonatal death still remains a 
significant concern70,71. Several leading causes of death in infants are of infectious 
origin71,72. Therefore, it is critical to gain a better understanding of differences between 
adult and neonatal immunity in order to deign more effective therapeutic regimens.  
My thesis focuses on understanding and identifying the underlying mechanisms 
for the differences between adult and neonatal CD8+ T cells. Due to the complexity and 
ethical concerns of human studies, we, like many other researchers, choose to use 
murine models to address immunological questions. Murine models provide a 
genetically tractable system to investigate the basic biology of infant immunity.  
Historically, neonates were thought to have immature adaptive immune systems 
with compromised immune responses, rendering them more susceptible to infections. 
Surprisingly, we found that neonatal CD8+ T cells are capable of forming effector cells 
post-infection73. In fact, neonatal CD8+ T cells respond vigorously to activation, 
neonatal CD8+ T cells proliferate more rapidly than adult CD8+ T cells and become 
quickly terminal differentiated73,74,31. Thus, neonatal CD8+ T cells have a significantly 
larger percent of SLECs and less MPECs than adult CD8+ T cells after infection73. 
Neonatal CD8+ T cells form poor immunological memory post-infection, which 
contribute to their poor ability to combat secondary infection. This could be due to their 
more terminally differentiated status73. Our data suggest that neonatal neonates are 
more susceptible to repeated infections not because they have immature immune 
systems, but due to their failure to form protective long-term memory (Figure 2).  
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Figure 1.2. Schematics of adult and neonatal CD8+ T cell responses. 
 
Naïve neonatal CD8+ T cells contain a larger percent of virtual memory cells than 
adults measured by expression of the memory phenotype markers, CD44 and CD12260. 
This is at least partially due to a more lymphopenic environment in early life75. Age-
dependent differences in percentages of virtual memory cells are not likely driven by IL-
4 induction because even after developing within the same thymic environment with 
similar IL-4 availability, neonatal thymocytes still gave rise to more memory phenotype 
CD8+ T cells in the periphery compared to adult thymocytes60.   
As mentioned above in the layered immune system section, we have further 
shown that neonatal CD8+ T cells adopt different fates than adult cells because they 
originate from different progenitors60. Our data also suggest that a developmental-
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regulated RNA binding protein Lin28b plays an important role in shaping neonatal CD8+ 
T cell response60.  
Lin28 is a RNA binding protein that is well conserved across species, ranging 
from Drosophila to human76,77. Lin28a and Lin28b are the two isoforms of Lin28 
proteins. They are considered equivalent since they share almost identical sequence76. 
Lin28 is highly expressed in early life and has been shown to promote fetal 
hematopoiesis78–80. The best-known target of Lin28, microRNA let-7 is highly expressed 
in adulthood76,77. Lin28 can inhibit let-7 biogenesis, which explains the reverse 
relationship of their level of expression during development76,77. Let-7 represses a wide 
array of targets, including oncogenes (Myc, Hmga2, etc.), insule-PI3K-mTOR pathway 
and cell cycle regulators (cyclins and cyclin-dependent kinase)76,77. Lin28 promotes the 
activities of let-7 downstream targets by inhibiting let-7 production. Another proposed 
target of Lin28 is mTOR pathway77,81. In addition to act on mTOR in a let-7 dependent 
manner, it has been shown that Lin28 can also directly promote mTOR activities by 
stabilizing some critical components (Igf2, etc.) transcriptionally81.  
Previous studies have shown that mTOR is important in regulate CD8+ T cell 
differentiation at least in adult animals, and mTOR acts mostly through mTOR complex 
1 (mTORC1)82,83. mTOR is an ubiquitously expressed protein kinase that carries out its 
function by phosphorylating downstream targets. mTOR has been proved to regulate 
cellular metabolism and growth83. There are 2 complexes (mTORC1 and mTORC2) 
formed by mTOR with other proteins. mTORC1 has been shown to be the major 
regulatory complex of cell metabolism, and it is better studied and understood than 
mTORC2 in T cells. Its role in neonatal CD8+ T cells has been examined in this thesis, 
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yet more experiments are required to understand the mechanism better.  
The underlying mechanisms for these age-related differences still remain 
unknown. Future studies are called for improve our understanding on CD8+ T cells 
response in early life.  
Research Objectives    
Understanding of CD8+ T cell biology has advanced drastically in the past 
several decades, but there are still many gaps in our knowledge of CD8+ T cell biology, 
particularly regarding the differences in CD8+ T cell behavior in early life. The 
overarching objective of this thesis is to investigate the developmental differences 
between adult and neonatal CD8+ T cell responses and the factors contributing to their 
different behaviors. We hypothesized that neonatal CD8+ T cells are derived from a 
distinct progenitor and utilize different metabolic program. In this thesis, experiments 
have been conducted to investigate the layered CD8+ T cell responses, the metabolic 
pathways used by different aged CD8+ T cells and the environmental impact on CD8+ T 
cell development. The findings provide a more comprehensive picture of neonatal CD8+ 
T cell response and how it is regulated. Our work also identify cellular pathways that are 
differentially utilized in neonatal CD8+ T cells, which can serve as potential drug targets 
in therapy development.  
 
 
 
 
 
  
 17 
REFERENCES: 
1.  Godfrey DI, Kennedy J, Suda T, Zlotnik A. A developmental pathway involving 
four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-
negative adult mouse thymocytes defined by CD44 and CD25 expression. J 
Immunol. 1993;150(10). 
2.  Murphy JB. Factors of Resistance to Heteroplastic Tissue-Grafting : Studies in 
Tissue Specificity. III. J Exp Med. 1914;19(5):513-522. 
3.  Silverstein AM. The lymphocyte in immunology: from James B. Murphy to James 
L. Gowans. Nat Immunol. 2001;2(7):569-571. 
4.  Gowans JL, Knight EJ. The Route of Re-Circulation of Lymphocytes in the Rat. 
Proc R Soc London B Biol Sci. 1964;159(975). 
5.  Gowans JL, Uhr JW. The carriage of immunological memory by small 
lymphocytes in the rat. J Exp Med. 1966;124(5):1017-1030. 
6.  Ellis ST, Gowans JL. The Role of Lymphocytes in Antibody Formation. V. 
Transfer of Immunological Memory to Tetanus Toxoid: The Origin of Plasma Cells 
from Small Lymphocytes, Stimulation of Memory Cells in vitro and the Persistence 
of Memory after Cell-Transfer. Proc R Soc London B Biol Sci. 1973;183(1071). 
7.  Howard JC, Gowans JL. The Role of Lymphocytes in Antibody Formation. III. The 
Origin from Small Lymphocytes of Cells Forming Direct and Indirect Haemolytic 
Plaques to Sheep Erythrocytes in the Rat. Proc R Soc London B Biol Sci. 
1972;182(1067). 
8.  Miller JFAP, Mitchell GF. The Thymus and the Precursors of Antigen Reactive 
Cells. Nature. 1967;216(5116):659-663. 
9.  Miller JFAP. Immunological Function of the Thymus. Lancet. 1961;278(7205):748-
749. 
10.  Mitchell GF, Miller JFAP. Immunological activity of thymus and thoracic-duct 
lymphocytes. Proc Natl Acad Sci U S A. 1968;59(1):296-303. 
11.  Kisielow P, Hirst JA, Shiku H, et al. Ly antigens as markers for functionally distinct 
  
 18 
subpopulations of thymus-derived lymphocytes of the mouse. Nature. 
1975;253(5488):219-220. 
12.  Shiku H, Kisielow P, Bean MA, et al. Expression of T-cell differentiation antigens 
on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional 
heterogeneity related to the surface phenotype of T cells. J Exp Med. 
1975;141(1). 
13.  Cantor H, Boyse EA. Functional subclasses of T-lymphocytes bearing different Ly 
antigens. I. The generation of functionally distinct T-cell subclasses is a 
differentiative process independent of antigen. J Exp Med. 1975;141(6). 
14.  Yanagi Y, Yoshikai Y, Leggett K, Clark SP, Aleksander I, Mak TW. A human T 
cell-specific cDNA clone encodes a protein having extensive homology to 
immunoglobulin chains. Nature. 1984;308(5955):145-149. 
15.  Hedrick SM, Nielsen EA, Kavaler J, Cohen DI, Davis MM. Sequence relationships 
between putative T-cell receptor polypeptides and immunoglobulins. Nature. 
1984;308(5955):153-158. 
16.  Hedrick SM, Cohen DI, Nielsen EA, Davis MM. Isolation of cDNA clones encoding 
T cell-specific membrane-associated proteins. Nature. 1984;308(5955):149-153. 
17.  McIntyre BW, Allison JP. The mouse T cell receptor: Structural heterogeneity of 
molecules of normal T cells defined by Xenoantiserum. Cell. 1983;34(3):739-746. 
18.  Kappler J, Kubo R, Haskins K, White J, Marrack P. The mouse T cell receptor: 
Comparison of MHC-restricted receptors on two T cell hybridomas. Cell. 
1983;34(3):727-737. 
19.  Kappler J, Kubo R, Haskins K, et al. The major histocompatibility complex-
restricted antigen receptor on T cells in mouse and man: Identification of constant 
and variable peptides. Cell. 1983;35(1):295-302. 
20.  John B, Harris TH, Tait ED, et al. Dynamic Imaging of CD8+ T Cells and Dendritic 
Cells during Infection with Toxoplasma gondii. Riley EM, ed. PLoS Pathog. 
2009;5(7):e1000505. 
21.  Hickman HD, Takeda K, Skon CN, et al. Direct priming of antiviral CD8+ T cells in 
  
 19 
the peripheral interfollicular region of lymph nodes. Nat Immunol. 2008;9(2):155-
165. 
22.  Sarkar S, Kalia V, Haining WN, Konieczny BT, Subramaniam S, Ahmed R. 
Functional and genomic profiling of effector CD8 T cell subsets with distinct 
memory fates. J Exp Med. 2008;205(3). 
23.  Joshi NS, Cui W, Chandele A, et al. Inflammation Directs Memory Precursor and 
Short-Lived Effector CD8+ T Cell Fates via the Graded Expression of T-bet 
Transcription Factor. Immunity. 2007;27(2):281-295. 
24.  Takemoto N, Intlekofer AM, Northrup JT, Wherry EJ, Reiner SL. Cutting Edge: IL-
12 Inversely Regulates T-bet and Eomesodermin Expression during Pathogen-
Induced CD8+ T Cell Differentiation. J Immunol. 2006;177(11). 
25.  Schulz O, Hammerschmidt SI, Moschovakis GL, Förster R. Chemokines and 
Chemokine Receptors in Lymphoid Tissue Dynamics. Annu Rev Immunol. 
2016;34(1):203-242. 
26.  Berke G. The CTL’s kiss of death. Cell. 1995;81(1):9-12. 
27.  Harty JT, Bevan MJ. Responses of CD8+ T cells to intracellular bacteria. Curr 
Opin Immunol. 1999;11(1):89-93. 
28.  Obar JJ, Lefrançois L. Memory CD8+ T cell differentiation. Ann N Y Acad Sci. 
2010;1183:251-266. 
29.  Schenkel JM, Masopust D. Tissue-Resident Memory T Cells. Immunity. 
2014;41(6):886-897. 
30.  Jameson SC, Lee YJ, Hogquist KA. Innate Memory T cells. In: ; 2015:173-213. 
31.  Le Campion A, Bourgeois C, Lambolez F, et al. Naive T cells proliferate strongly 
in neonatal mice in response to self-peptide/self-MHC complexes. Proc Natl Acad 
Sci U S A. 2002;99(7):4538-4543. 
32.  Wang LD, Wagers AJ. Dynamic niches in the origination and differentiation of 
haematopoietic stem cells. Nat Rev Mol Cell Biol. 2011;12(10):643-655. 
  
 20 
33.  Babovic S, Eaves CJ. Hierarchical organization of fetal and adult hematopoietic 
stem cells. Exp Cell Res. 2014;329(2):185-191. 
34.  Palis J, Robertson S, Kennedy M, Wall C, Keller G. Development of erythroid and 
myeloid progenitors in the yolk sac and embryo proper of the mouse. 
Development. 1999;126(22). 
35.  Copley MR, Beer PA, Eaves CJ, et al. Hematopoietic stem cell heterogeneity 
takes center stage. Cell Stem Cell. 2012;10(6):690-697. 
36.  Crisan M, Dzierzak E. The many faces of hematopoietic stem cell heterogeneity. 
Development. 2016;143(24). 
37.  Berkahn L, Keating A. Hematopoiesis in the Elderly. Hematology. 2004;9(3):159-
163. 
38.  Cho RH, Sieburg HB, Muller-Sieburg CE. A new mechanism for the aging of 
hematopoietic stem cells: aging changes the clonal composition of the stem cell 
compartment but not individual stem cells. Blood. 2008;111(12). 
39.  Dykstra B, Kent D, Bowie M, et al. Long-term propagation of distinct 
hematopoietic differentiation programs in vivo. Cell Stem Cell. 2007;1(2):218-229. 
40.  Pawliuk R, Eaves C, Humphries R. Evidence of both ontogeny and transplant 
dose-regulated expansion of hematopoietic stem cells in vivo. Blood. 1996;88(8). 
41.  Fleming W, Alpern E, Uchida N, Ikuta K, Spangrude G, Weissman I. Functional 
heterogeneity is associated with the cell cycle status of murine hematopoietic 
stem cells. J Cell Biol. 1993;122(4). 
42.  Bowie MB, Kent DG, Dykstra B, et al. Identification of a new intrinsically timed 
developmental checkpoint that reprograms key hematopoietic stem cell 
properties. Proc Natl Acad Sci U S A. 2007;104(14):5878-5882. 
43.  Manesia JK, Xu Z, Broekaert D, et al. Highly proliferative primitive fetal liver 
hematopoietic stem cells are fueled by oxidative metabolic pathways. Stem Cell 
Res. 2015;15(3):715-721. 
  
 21 
44.  Benz C, Copley MR, Kent DG, et al. Hematopoietic stem cell subtypes expand 
differentially during development and display distinct lymphopoietic programs. Cell 
Stem Cell. 2012;10(3):273-283. 
45.  Montecino-Rodriguez E, Dorshkind K, Park TS, et al. B-1 B cell development in 
the fetus and adult. Immunity. 2012;36(1):13-21. 
46.  Wong S-C, Chew W-K, Tan JE-L, Melendez AJ, Francis F, Lam K-P. Peritoneal 
CD5+ B-1 cells have signaling properties similar to tolerant B cells. J Biol Chem. 
2002;277(34):30707-30715. 
47.  Morris DL, Rothstein TL. Abnormal transcription factor induction through the 
surface immunoglobulin M receptor of B-1 lymphocytes. J Exp Med. 1993;177(3). 
48.  Ha S, Tsuji M, Suzuki K, et al. Regulation of B1 cell migration by signals through 
Toll-like receptors. J Exp Med. 2006;203(11). 
49.  Yang Y, Tung JW, Ghosn EEB, Herzenberg LA, Herzenberg LA. Division and 
differentiation of natural antibody-producing cells in mouse spleen. Proc Natl Acad 
Sci U S A. 2007;104(11):4542-4546. 
50.  Hayakawa K, Hardy RR, Herzenberg LA, Herzenberg LA. Progenitors for Ly-1 B 
cells are distinct from progenitors for other B cells. J Exp Med. 1985;161(6):1554-
1568. 
51.  Montecino-Rodriguez E, Leathers H, Dorshkind K. Identification of a B-1 B cell–
specified progenitor. Nat Immunol. 2006;7(3):293-301. 
52.  Griffin DO, Holodick NE, Rothstein TL. Human B1 cells in umbilical cord and adult 
peripheral blood express the novel phenotype CD20 + CD27 + CD43 + CD70 −. J 
Exp Med. 2011;208(1):67-80. 
53.  Ikuta K, Kina T, MacNeil I, et al. A developmental switch in thymic lymphocyte 
maturation potential occurs at the level of hematopoietic stem cells. Cell. 
1990;62(5):863-874. 
54.  Mold JE, Venkatasubrahmanyam S, Burt TD, et al. Fetal and Adult Hematopoietic 
Stem Cells Give Rise to Distinct T Cell Lineages in Humans. Science (80- ). 
2010;330(6011). 
  
 22 
55.  Zhang X, Mozeleski B, Lemoine S, et al. CD4 T Cells with Effector Memory 
Phenotype and Function Develop in the Sterile Environment of the Fetus. Sci 
Transl Med. 2014;6(238). 
56.  Rose S, Lichtenheld M, Foote MR, Adkins B. Murine Neonatal CD4+ Cells Are 
Poised for Rapid Th2 Effector-Like Function. J Immunol. 2007;178(5). 
57.  Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of 
age. Nat Rev Immunol. 2004;4(7):553-564. doi:10.1038/nri1394. 
58.  Adkins B, Hamilton K. Freshly isolated, murine neonatal T cells produce IL-4 in 
response to anti-CD3 stimulation. J Immunol. 1992;149(11):3448-3455. 
59.  Adkins B, Bu Y, Guevara P. Murine neonatal CD4+ lymph node cells are highly 
deficient in the development of antigen-specific Th1 function in adoptive adult 
hosts. J Immunol. 2002;169(9):4998-5004. 
60.  Wang J, Wissink EM, Watson NB, Smith NL, Grimson A, Rudd BD. Fetal and 
adult progenitors give rise to unique populations of CD8+ T cells. Blood. 
2016;128(26). 
61.  Fink PJ. The Biology of Recent Thymic Emigrants. Annu Rev Immunol. 
2013;31(1):31-50. 
62.  Opiela SJ, Koru-Sengul T, Adkins B. Murine neonatal recent thymic emigrants are 
phenotypically and functionally distinct from adult recent thymic emigrants. Blood. 
2009;113(22):5635-5643. 
63.  Buck MD, O’Sullivan D, Pearce EL. T cell metabolism drives immunity. J Exp 
Med. 2015;212(9):1345-1360. 
64.  O’Neill LAJ, Kishton RJ, Rathmell J. A guide to immunometabolism for 
immunologists. Nat Rev Immunol. 2016;16(9):553-565. 
65.  Pearce EL, Poffenberger MC, Chang C-H, Jones RG. Fueling immunity: insights 
into metabolism and lymphocyte function. Science (80- ). 2013;342(6155). 
66.  Warburg O. The Metabolism of Carcinoma Cells. J Cancer Res. 1925;9(1):148-
  
 23 
163. 
67.  Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg 
effect: the metabolic requirements of cell proliferation. Science. 
2009;324(5930):1029-1033. 
68.  van der Windt GJW, O’Sullivan D, Everts B, et al. CD8 memory T cells have a 
bioenergetic advantage that underlies their rapid recall ability. Proc Natl Acad Sci 
U S A. 2013;110(35):14336-14341. 
69.  Pathirana J, Muñoz FM, Abbing-Karahagopian V, et al. Neonatal death: Case 
definition &amp; guidelines for data collection, analysis, and presentation of 
immunization safety data. Vaccine. 2016;34(49):6027-6037. 
70.  UNICEF, WHO, World Bank, UN. WHO | Levels and trends in child mortality 
2014. WHO. 2014. 
71.  GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and 
national age–sex specific all-cause and cause-specific mortality for 240 causes of 
death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 
2013. Lancet. 2015;385(9963):117-171. 
72.  Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 
causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the 
Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-2128. 
73.  Smith NL, Wissink E, Wang J, et al. Rapid proliferation and differentiation impairs 
the development of memory CD8+ T cells in early life. J Immunol. 
2014;193(1):177-184. 
74.  Reynaldi A, Smith NL, Schlub TE, Venturi V, Rudd BD, Davenport MP. Modeling 
the dynamics of neonatal CD8+ T-cell responses. Immunol Cell Biol. 
2016;94(9):838-848. 
75.  Min B, McHugh R, Sempowski GD, Mackall C, Foucras G, Paul WE. Neonates 
Support Lymphopenia-Induced Proliferation. Immunity. 2003;18(1):131-140. 
76.  Tsialikas J, Romer-Seibert J. LIN28: roles and regulation in development and 
beyond. Development. 2015;142(14):2397-2404. 
  
 24 
77.  Shyh-Chang N, Daley GQ. Cell Stem Cell Lin28: Primal Regulator of Growth and 
Metabolism in Stem Cells. Stem Cell. 2013;12:395-406. 
78.  Bronevetsky Y, Burt TD, McCune JM. Lin28b Regulates Fetal Regulatory T Cell 
Differentiation through Modulation of TGF-β Signaling. J Immunol. 
2016;197(11):4344-4350. 
79.  Zhou Y, Li Y-S, Bandi SR, et al. Lin28b promotes fetal B lymphopoiesis through 
the transcription factor Arid3a. J Exp Med. 2015;212(4):569-580. 
80.  Yuan J, Nguyen CK, Liu X, Kanellopoulou C, Muljo SA. Lin28b reprograms adult 
bone marrow hematopoietic progenitors to mediate fetal-like lymphopoiesis. 
Science. 2012;335(6073):1195-1200. 
81.  Zhu H, Shyh-Chang N, Segrè A V, et al. The Lin28/let-7 axis regulates glucose 
metabolism. Cell. 2011;147(1):81-94. 
82.  Araki K, Turner AP, Shaffer VO, et al. mTOR regulates memory CD8 T-cell 
differentiation. Nature. 2009;460(7251):108-112. 
83.  Araki K, Youngblood B, Ahmed R. The role of mTOR in memory CD8 T-cell 
differentiation. Immunol Rev. 2010;235(1):234-243. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 25 
CHAPTER TWO 
Fetal and Adult Progenitors Give Rise to Unique Population of CD8+ T Cells§ 
 
Jocelyn Wang,1,* Erin M. Wissink,2,* Neva B. Watson,1,* Norah L. Smith,1 Andrew 
Grimson,2,† and Brian D. Rudd1,†  
1Department of Microbiology and Immunology, Cornell University, Ithaca, NY  
2Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 
 
*J.W., E.M.W., and N.B.W. are considered joint first authors. 
†A.G. and B.D.R. are considered joint senior authors. 
§This manuscript was published in December 2016 in Blood. Reprinted with permission. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 26 
SUMMARY 
During the ontogeny of the mammalian immune system, distinct lineages of cells 
arise from fetal and adult hematopoietic stem cells (HSCs) during specific stages of 
development. However, in some cases, the same immune cell type is produced by both 
HSC populations, resulting in the generation of phenotypically similar cells with distinct 
origins and divergent functional properties. In this report, we demonstrate that neonatal 
CD8+ T cells preferentially become short-lived effectors and adult CD8+ T cells 
selectively form long-lived memory cells after infection because they are derived from 
distinct hematopoietic stem cells. Notably, we find that naïve neonatal CD8+ T cells 
originate from a progenitor cell that is distinguished by expression of Lin28b. 
Remarkably, ectopic expression of Lin28b enables adult progenitors to give rise to 
CD8+ T cells that are phenotypically and functionally analogous to those found in 
neonates. These findings suggest that neonatal and adult CD8+ T cells belong to 
separate lineages of CD8+ T cells, and potentially explain why it is challenging to elicit 
memory CD8+ T cells in early life. 
INTRODUCTION 
Neonates often generate incomplete immunity against intracellular bacteria and 
viruses. Because CD8+ T cells play a critical role in protecting the host against these 
pathogens, it is important to understand how and why neonatal CD8+ T cells respond to 
infection differently than in adults. Recent studies suggest that neonatal CD8+ T cells 
fail to become memory cells because of an inherent propensity to rapidly proliferate and 
become terminally differentiated after antigenic stimulation.1-3 However, the underlying 
basis for these age-related differences remains unknown.  
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Several models might explain why neonatal CD8+ T cell adopt fates different 
from those of adults during infection. First, the “proliferation model” posits that 
developmental changes in the CD8+ T-cell response relate to differences in 
homeostatic proliferation before infection. When naïve CD8+ T cells enter a 
lymphopenic environment, they divide rapidly in response to homeostatic cytokines and 
upregulate phenotypic markers (CD44, CD122) indicative of cell differentiation.4,5 Thus, 
because newborn mice are nearly devoid of peripheral CD8+ T cells, it is possible that 
neonatal CD8+ T cells are less likely to develop into memory CD8+ T cells because the 
starting population is more differentiated than adults before infection.  
Another possibility relates to the distinct hematopoietic stem cell (HSC) lineages 
that generate neonatal and adult CD8+ T cells (“origin model”). Although neonatal CD8+ 
T cells are derived from fetal liver HSCs that colonize the thymus during mid-gestation 
(approximately embryonic day [e] 13), adult CD8+ T cells are produced from bone 
marrow (BM) HSCs that seed the thymus just before birth (~e20). Importantly, fetal 
HSCs turn over more rapidly6 and preferentially give rise to innate-like lymphocytes 
compared with adult HSCs.7 Thus, it is also possible that neonatal CD8+ T cells fail to 
form memory cells because they are created from distinct progenitor cells.  
To discriminate between the proliferation and origin models, we compared 
neonatal and adult CD8+ T cells that had undergone equivalent homeostatic 
proliferation in the periphery, or were at the same stage of development in the thymus. 
We also compared T-cell maturation by fetal and adult precursors in the adult thymus 
and examined whether fetal-derived CD8+ T cells respond differently to infection than 
their adult counterparts. Collectively, our data reject the proliferation model and support 
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the origin model, and imply that neonatal and adult CD8+ T cells adopt different fates 
after infection because they belong to separate lineages of naïve CD8+ T cells derived 
from distinct progenitors.  
MATERIALS AND METHODS  
Mice  
B6-Ly5.2/Cr mice were purchased from Charles River Laboratories (Frederick, 
MD). TCR transgenic mice specific for the HSV-1 glycoprotein B498-505 peptide 
SSIEFARL8 (gBT-I mice) were provided by Janko Nikolich-Zugich (University of 
Arizona, Tucson, AZ) and crossed with Thy1.1 or C57BL/6 mice purchased from 
Jackson Laboratories (Bar Harbor, ME). Neonatal and adult gBT-I animals were used at 
6 to 8 days old and at 2 to 4 months old, respectively. Mice with a tetracycline-inducible 
copy of human LIN28B on a C57BL/6 background (iLin28b mice) were obtained from 
George Daley (Harvard University, Cambridge, MA).9 Male mice were used for all 
experiments, and mice were housed under specific pathogen-free conditions at Cornell 
University College of Veterinary Medicine, accredited by the Assessment and 
Accreditation of Laboratory Animal Care.  
Antibodies and flow cytofluorimetric analysis  
Antibodies were purchased from eBioscience (San Diego, CA), Biolegend (San 
Diego, CA), Invitrogen (Carlsbad, CA), or BD Biosciences (Mountain View, CA). Sheep 
anti-human Lin28b was obtained from R&D Systems (Minneapolis, MN), and Alexa 
Fluor 488 rabbit-anti-sheep from Jackson Immunoresearch (West Grove, PA). Flow 
cytofluorimetric data were acquired using DiVa software from an LSRII equipped with 4 
lasers (BD Biosciences). Analysis was performed with FlowJo (Tree Star, Ashland, OR). 
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Cell sorting  
To purify subsets of CD44hiCD122hi and CD44loCD122lo CD8+ T cells from 
neonatal and adult gBT-I mice, CD8+ T cells were enriched using anti-CD8a 
microbeads (Miltenyi Biotec) and were subsequently labeled with antibodies against 
CD4, CD8, CD44, and CD122 and sorted to >95% purity on a fluorescence-activated 
cell sorting (FACS) Aria III (BD Biosciences). To purify single-positive (SP; CD8+CD4–) 
thymocytes from neonatal and adult gBT-I mice, CD4+ thymocytes were depleted by 
negative immunomagnetic selection via biotinylated antibody followed by streptavidin-
coated microbeads (Miltenyi Biotec). Thymocytes were labeled with antibodies against 
CD4, CD8, Va2, and Vb8, and FACS-sorted to >90% purity. To isolate donor CD8+ T 
cells from chimeric mice, CD4+, CD19+, MHC-II+, and Ter119+ cells were depleted by 
negative immunomagnetic selection. Cells were labeled with antibodies against CD8, 
CD4, CD45.1, CD45.2, Thy1.1, and Thy1.2, and FACS-sorted to >98% purity for 
adoptive cotransfers. Antibodies against Va2 and Vb8 were added for sorts intended for 
RNA isolation.  
In vitro stimulation of CD8+ T cells  
SP CD8+ thymocytes were FACS-sorted from neonatal and adult gBT-I mice and 
labeled with carboxyfluorescein diacetate succinimidyl ester, as described,1 and cells 
were stimulated with plate-bound anti-CD3 (5 mg/mL) and anti-CD28 (20 mg/mL).  
Intrathymic injection  
To compare the progeny of different aged progenitor cells, we adapted a protocol 
from Adkins B.10 B6-Ly5.2 recipient mice were sublethally irradiated with 600 rads and 
injected intrathymically with 1×106 double-negative (DN, CD8–CD4–) thymocytes from 
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fetal gBT-I Thy1.2 mice (14 days’ gestation) and adult gBT-I Thy1.1 mice. CD8–CD4– 
thymocytes were isolated from adult mice by depleting CD8+ and CD4+ cells using 
negative magnetic separation. Because 100% of thymocytes on embryonic day 14 are 
CD8–CD4– cells,10 whole thymocyte preparations were used from fetal gBT-I mice. 
Splenic CD8+ T cells were recovered 4 weeks posttransfer and cotransferred into new 
B6-Ly5.2 (CD45.1+Thy1.2+) recipients.  
Adoptive cotransfers  
To compare primary and secondary responses to infection, FACS-sorted splenic 
neonatal and adult CD44hiCD122hi or CD44loCD122lo CD8+ cells, or donor CD8+ cells 
from thymic transfers or BM chimeras were combined at a 1:1 ratio. Combined cells 
were suspended at 2×105 cells per mL of PBS and 100 ul of cells was injected i.v. into 
adult B6-Ly5.2 recipient mice. The next day, recipient mice were infected with WT LM-
gB (5×103 CFU, i.v.) and later challenged with WT LM-gB (5×104 CFU, i.v.), as 
described.1 
Bone marrow chimeras  
Single and mixed BM chimeras were generated by obtaining BM from 
congenically marked gBT-I (Thy1.1+CD45.2+) and gBT-I iLin28b (Thy1.2+CD45.2+) 
mice. CD4+ and CD8+ T cells were depleted by magnetic separation, and 1×107 cells 
were injected (5×106 cells per donor for mixed chimeras) into lethally irradiated (990 
rads) 7- to 8-week-old adult B6-Ly5.2 recipients. Forty-eight hours posttransplantation, 
mice were administered 1 mg/mL doxycycline with 10 mg/mL sucrose via drinking water 
to induce LIN28B expression for 8 weeks during reconstitution.  
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RNA sequencing  
For mRNA sequencing, libraries were generated using 25 to 200 ng total RNA 
with the NEBNext Ultra RNA Library Prep Kit for Illumina (NEB) and sequenced on an 
Illumina HiSequation 2500, generating 100-nucleotide reads. The analysis was 
performed as previously described.3 Reads were aligned with Tophat11 (mm9), and 
CuffDiff was used to quantify the abundance and differential expression of each mRNA, 
using a false discovery rate of 5% for significance.12 Small RNA libraries were 
generated using 50 to 100 ng of total RNA using the NEBNext Small RNA Library Kit 
(NEB), and sequenced on an Illumina HiSequation 2500, generating 50-nucleotide 
reads. The analysis was performed as previously described.3 miRNAs were mapped 
and quantified using MirDeep213 (MirBase version 21) with Bowtie14 (mm9). The data 
have been deposited in the GEO Small Read Archive15 under accession number 
GSE80597.  
Clustering was performed using the partitioning around the medoids method16 in 
R. Gene ontology was performed with DAVID17,18 to find enriched biological process 
terms with Benjamini-corrected P values < .05. Gene sets for enrichment statistics were 
downloaded from the Molecular Signatures Database (MSDB).19 For each cluster, we 
found the number of genes present in both the cluster and the data set (b), the total 
number of genes present in that cluster (n), the number of genes in the MSDB data set 
(B), and the total number of genes that had been clustered (N). Enrichment was 
calculated as (b/n)/(B/N). One-sided Fisher exact tests were used to measure 
significance.  
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Statistical analysis  
Statistical analysis was performed using Prism (GraphPad Software, Inc, La 
Jolla, CA). Error bars represent standard error of the mean. Significance was 
determined by Student t test or one-way analysis of variance followed by Tukey multiple 
comparisons test. Significance is denoted as: *P < .05, **P <  .01, ***P <  .001, and 
****P < .0001.  
RESULTS 
Neonatal and adult CD8+ T cells exhibit distinct phenotypes  
We first sought to test the proliferation model and determine whether differences 
in homeostatic proliferation contribute to cell-intrinsic changes in neonatal CD8+ T cells. 
To examine this possibility,  we stained CD8+ T cells from uninfected neonatal and adult 
gBT-I mice for CD44 and CD122, which are used to define cells that have undergone 
significant amounts of homeostatic proliferation. Such CD44
hi
CD122
hi are referred to as 
memory phenotype naïve cells, because they display certain characteristics of memory 
cells without having encountered foreign antigen.
20,21 The neonatal CD8+ T cells were 
comprised of twofold more CD44
hi
CD122
hi memory phenotype (MP) cells, whereas the 
adult CD8+ T cells were made up of more CD44
lo
CD122
lo true naïve (TN) cells (Figure 
1A-B). Importantly, we did not observe significant numbers of MP cells in the thymi of 
neonatal mice, and their appearance in the periphery coincided with the relative number 
of CD8+ T cells that are actively dividing, as measured by Ki-67 expression 
(supplemental Figure 1, available on the Blood Web site). Together, these data are 
consistent with earlier reports indicating that large number of CD8+ T cells undergo 
homeostatic expansion in early life.
22,23 We also compared the phenotype of neonatal 
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and adult MP CD8+ T cells in the periphery, and observed multiple age–related 
differences in the expression of natural killer cell receptors, activation markers, and T-
box transcription factors (Figure 1C). Thus, neonatal CD8+ T cells that have undergone 
homeostatic expansion in the periphery express a distinct phenotypic signature, even 
when compared with matched adult counterparts (Figure 1C).  
 
Figure 2.1. Memory phenotype CD8+ T cells are more abundant in early life and express 
different surface markers and transcription factors. (A) Surface expression of CD44 and 
CD122 by splenic CD8+ T cells from uninfected neonatal and adult gBT-I. (B) Statistical 
analysis of the percentages of MP cells from neonatal and adult gBT-I mice. (C) Comparison of 
various surface markers and transcription factors expressed in TN and MP cells from uninfected 
neonatal (line) or adult (shaded) gBT-I mice.  Data are representative of at least 3 experiments. 
Significance was determined by student t test. ****P < .0001. 
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Figure 2.2. Both TN and MP CD8+ T cells from uninfected neonatal gBT-I mice express 
different genes from adults. (A) Principal component analysis on RNA-Seq data. Mean FPKM 
values from well-expressed genes were used from adult and neonatal bulk (total), TN, and MP 
cells. Bulk adult, MP adult, and MP neonatal samples consist of 3 pooled biological replicates; 
bulk neonatal, TN adult, and TN neonatal samples consist of 2 pooled biological replicates. The 
percentage of the overall variation accounted for by principal components 1 (x-axis) and 2 (y-
axis) is indicated for each axis. Gene loadings for principal components 1 and 2 are shown in 
supplemental Figure 2. (B) Color-coded pairwise Spearman rank correlation coefficients 
comparing FPKM values for genes that are significantly differentially expressed between adults 
and neonates in at least 1 sample; P<1015 for all comparisons. (C) Gene expression values for 
adults and neonates in MP cells. Gray indicates lowly expressed genes, black indicates 
nondifferentially expressed genes, orange indicates the 126 genes upregulated in neonatal 
cells, and blue indicates the 159 genes upregulated in adult cells. (D) Gene expression values 
for adults and neonates in TN cells, where 204 genes are upregulated in neonatal cells and 195 
genes are upregulated in adult cells. (E) Clustering of genes in all samples. Fold-change 
differences for significantly differentially expressed genes were calculated between adults and 
neonates. Clustering was performed to identify genes with similar differences in expression in 
each sample; fold-change for each gene is plotted in each sample, and genes are shown in their 
clusters. (F) Genes in each cluster were compared with genes that define naïve cells before 
infection and effector or memory cells after infection. Enrichment was calculated as number of 
genes in each cluster compared with the number expected. Significance was determined by 
Fisher exact tests; *P < .05, **P< .005, ***P < .0005. See supplemental Table 1 for gene 
expression values and clustering. 
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TN and MP CD8+ T cells from different aged mice express distinct gene 
expression profiles  
We previously found that splenic neonatal CD8+ T cells upregulate genes 
needed for cell cycle progression and effector function,3 similar to adult MP cells.24 
Thus, gene expression differences observed between bulk adult and neonatal CD8+ T 
cells could be explained by the different proportions of MP and TN cells. To investigate 
this possibility, we sequenced transcriptomes from TN, MP, and bulk splenic cells from 
neonatal and adult mouse CD8+ T cells (supplemental Table 1). Instead, we found that 
adult cells were distinct from neonatal cells for all populations, which we visualized 
using principal component analysis (Figure 2A-B; see supplemental Figure 2 for 
transcripts contributing to differences). Hundreds of genes were differentially expressed 
between adults and neonates in both the TN and MP populations (Figure 2C-D), several 
of which were consistent with protein abundances observed in Figure 1C. Clustering 
genes by their expression patterns showed that most genes had equivalent expression 
differences between adults and neonates (clusters 1-4), whereas the remainder had 
age-dependent expression changes in the bulk CD8+ population alone (clusters 5-7, 
Figure 2E; supplemental Table 1). Upon comparing the genes in each cluster (Figure 
2E) with gene sets that characterize CD8+ T cells at different infection states,19,25 we 
found that genes upregulated in neonates in both MP and TN cells (cluster 4) are 
significantly enriched in genes typifying effector cells (Figure 2F) and gene ontology 
terms related to cell division (P< 10-8, supplemental Table 1). Similarly, genes 
downregulated in neonates in both MP and TN cells (clusters 2 and 3) are enriched in 
naïve and memory cell genes, consistent with previous data.3 Most gene expression 
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differences between adults and neonates therefore cannot be attributed simply to the 
increase in MP cells observed in early life.  
 
Figure 2.3. Both TN and MP CD8+ T cells from neonatal gBT-I mice preferentially become 
short-lived effectors after infection. (A) Schematic of experimental design: TN and MP cells 
were sorted from congenically marked gBT-I adult (CD45.2, Thy1.2) and neonatal (CD45.2, 
Thy1.1) mice and adoptively cotransferred (1:1 ratio) into adult recipient mice (CD45.1, Thy1.2). 
These recipients were infected with 5×103 colony-forming unit (CFU) LM-gB and serially bled to 
examine primary CD8+ T-cell responses. Recipients were also challenged at 28 dpi with 5×104 
WT LM-gB to assess the memory recall response. Arrows indicate days of infections. Relative 
numbers and ratios of TN (B) and MP (C) donor cells from different aged mice at various times 
after infection. Percentages of MP (D) and TN (E) donor cells from different aged mice that 
display a short-lived effector cell (SLEC) or memory precursor effector cell (MPEC) phenotype 
at the peak of the primary response (7 dpi). Data are representative of 2 experiments (n=9-12 
mice/group). Significance was assessed by Student t test (****P < .0001). DPI, days 
postinfection.  
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TN and MP CD8+ T cells from different aged mice respond differently to infection  
Next, we wanted to address whether neonatal CD8+ T cells preferentially 
become terminally differentiated during an immune response because a larger 
proportion of the naïve pool has undergone homeostatic proliferation before infection. 
We cotransferred equivalent phenotypic subsets (MP or TN cells) from neonatal and 
adult gBT-I mice into the same adult recipient mice (Figure 3A) and tracked their 
response to infection. Regardless of their initial phenotype, neonatal donor cells 
preferentially differentiated into short-lived effectors (SLECs; KLRG1hiCD127lo) during 
the effector stage (Figure 3D-E) and failed to transition into the long-lived memory pool. 
As a consequence, the memory recall response was almost entirely dominated by adult 
donor–derived cells (Figure 3B-C). Collectively, these data argue against the hypothesis 
that age-related differences in homeostatic proliferation underlie the altered behavior of 
different-aged CD8+ T cells after infection.  
Single positive CD8+CD4- thymocytes in neonatal mice exhibit unique genetic 
properties compared with adults  
We next sought to test the origin model and determine whether cell- intrinsic 
differences between neonatal and adult CD8+ T cells relate to their distinct HSC origin. 
We compared gene expression profiles in single-positive (SP) CD8+ T cells from 
neonatal and adult thymi to compare transcriptomes at the same stage of thymic 
development, and to control for age-related differences in maturation and proliferation 
(supplemental Table 1; validated protein levels of selected genes in supplemental 
Figure 3). Overall, we found greater variation between splenic and thymic CD8+ T cells, 
regardless of age (Figure 4A-B). Widespread gene expression differences do exist 
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between adults and neonates in both types of cells (Figure 4C-D and supplemental 
Table 1), however, indicating that neonatal CD8+ T cells exhibit a divergent pattern of 
gene expression even at the time they are initially created. To gain insight into these 
differences, we clustered genes based on their coexpression patterns (Figure 4E-F; 
supplemental Table 1). Genes with differential expression between adults and neonates 
in the spleen generally have similar differences in the thymus (clusters 1 and 5), yet 
additional genes show differences in the thymus only. Interestingly, genes that are 
upregulated only in the neonatal thymus (cluster 3) are enriched in effector-cell genes, 
suggesting that neonatal CD8+ T cells are more effectorlike. Genes that are 
downregulated in splenic neonates with little difference in thymic cells (cluster 4) have 
memory like expression, whereas genes downregulated in neonates in both the thymus 
and spleen (cluster 5) are enriched for genes found in naïve cells. Overall, differences in 
gene expression between neonatal and adult CD8+ T cells, beginning at the cells’ 
generation and continuing throughout the course of development, suggest neonatal 
CD8+ T cells represent a distinct and more effector like population of lymphocytes that 
associates with their progenitor cell origin.  
To uncover functional differences between thymic CD8+ T cells from neonatal 
and adult mice, we compared the ability of SP CD8+ T cells from neonatal and adult 
thymi to proliferate after in vitro stimulation. We found that neonatal SP CD8+ T cells 
had divided significantly more than their adult counterparts (supplemental Figure 5). 
Thus, the enhanced ability of peripheral neonatal CD8+ T cells to proliferate after 
stimulation appears to originate in their immediate precursors in the thymus.  
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Figure 2.4. Neonatal single-positive CD8+ T cells from the thymus express different 
genes and proliferate faster than adults. (A-F) RNAseq was performed on neonate and adult 
gBT-I CD8+ thymocytes and splenocytes. (A) Principal component analysis. Mean FPKM 
values from well-expressed genes were used from adult and neonatal na ̈ıve splenic and thymic 
CD8+ T cells. The naïve splenic adult sample consists of 3 pooled biological replicates; the 
remaining samples consist of 2 pooled biological replicates. The percentage of the overall 
variation accounted for by principal components 1 (x-axis) and 2 (y-axis) is indicated for each 
axis. Gene loadings are shown for principal components 1 and 2 in supplemental Figure 4. (B) 
Color-coded pairwise Spearman rank correlation coefficients comparing FPKM values for genes 
that are significantly differentially expressed between adults and neonates in at least one 
sample; P<1015 for all comparisons. (C) Gene expression values for adults and neonates in 
splenic cells. Gray indicates lowly expressed genes, black indicates nondifferentially expressed 
genes, orange indicates the 118 genes upregulated in neonatal cells, and blue indicates the 153 
genes upregulated in adult cells. (D) Gene expression values for adults and neonates in thymic 
cells, where 264 genes are upregulated in neonatal cells and 199 genes are upregulated in 
adult cells. Clustering of genes in naïve splenic and thymic CD8+ T-cell transcriptomes. Fold-
change differences for significantly differentially expressed genes were calculated between 
adults and neonates. (E) Clustering was performed to identify genes with similar differences in 
expression in each sample; fold-change for each gene is plotted in each sample, and genes are 
shown in their clusters. (F) Genes in each cluster were compared with genes that define naïve, 
effector, or memory cells. Enrichment was calculated as number of genes in each cluster 
compared with the number expected. See supplemental Table 1 for gene expression values and 
clustering.  
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Fetal progenitors give rise to mature CD8+ T cells that adopt distinctive fates after 
infection  
To confirm that thymic precursors in neonate and adult mice give rise to distinct 
lineages of CD8+ T cells, we intrathymically injected equivalent numbers of DN 
thymocytes from fetal and adult gBT-I mice into adult recipient mice, allowing us to 
control for age-related differences in the thymic stromal environment (Figure 5A). Four 
weeks after injection, we collected the peripheral cells and compared their phenotype. 
Strikingly, nearly 100% of fetal-derived CD8+ T cells were MP cells, whereas adult-
derived CD8+ T cells were comprised of many more TN cells (Figure 5B-C). To 
determine whether the progeny of fetal and adult precursors behaved similarly to 
neonatal and adult CD8+ T cells after microbial challenge, we cotransferred fetal- and 
adult-derived CD8+ T cells into adult recipient mice and compared their ability to 
respond to infection. We found that fetal-derived cells exhibited a terminally 
differentiated phenotype at the peak of the primary response (7dpi), and failed to 
survive during later stages of the infection (Figure 5D-E). As a result, the memory recall 
response was largely comprised of adult-derived CD8+ T cells (Figure 5D). Collectively, 
these data support the origin model, and suggest that neonatal and adult CD8+ T cells 
adopt different fates after infection because they are derived from different progenitor 
cells.  
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Figure 2.5. Fetal progenitors give rise to mature CD8+ T cells that adopt different fates 
after infection. (A) Schematic of experimental design: CD8-CD4- progenitors from congenically 
marked gBT-I adult (CD45.2, Thy1.1) and neonatal (CD45.2, Thy1.2) mice were transferred by 
intrathymic injection into sublethally irradiated congenic recipient mice (CD45.1, Thy1.2) 
separately. Four weeks later, progenitor-derived splenic CD8+ T cells were sorted and 
adoptively co-transferred (1:1 ratio) into new congenic recipient mice (CD45.1, Thy1.2). These 
recipients were infected with 5×103 LM-gB and serially bled to examine CD8+ T-cell responses. 
(B-C) Naïve phenotypes of progenitor-derived CD8+ T cells before adoptive cotransfer. (B) 
Representative plots displaying CD44 and CD122 expression by gBT-I progenitor-derived CD8+ 
T cells 4 weeks post–intrathymic transfer in blood. (C) Statistical analysis of the percentages of 
MP cells from gBT-I adult and fetal progenitor-derived cells. (D) Relative numbers of gBT-I adult 
(dashed) and fetal (solid) progenitor-derived donor CD8+ T cells postinfection and re-challenge 
(5×104 WT LM-gB); arrows indicate days of infections. (E) Percentages of gBT-I adult and fetal 
progenitor-derived donor CD8+ T cells that are SLECs and MPECs. Data are representative of 
2 experiments (n=4-11 mice/group) (****P<.0001).   
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Lin28b reprograms adult CD8+ T cells to behave more like neonatal cells  
Previous reports suggest that many key biological differences between fetal and 
adult HSCs can be attributed to changes in the expression of Lin28b, a conserved and 
developmentally regulated RNA-binding protein that represses the let-7 microRNA,26,27 
among other roles. Importantly, Lin28b is selectively expressed in fetal progenitors 
(supplemental Figure 6), and overexpression of Lin28b in adult BM cells promotes the 
development of fetal-like B cells (B-1a B cells, marginal zone B cells) and innate-like T 
cells (NKT cells, γδT cells).28 If Lin28b underlies key developmental-related differences 
in CD8+ T cells, we reasoned that ectopic expression of Lin28 in adult progenitor cells 
would result in the development of “neonatal-like” cells. To test this, we generated BM 
chimeras by reconstituting lethally irradiated mice with gBT-I WT or iLin28b 
hematopoietic cells (Figure 6A). After reconstitution, robust expression of Lin28b was 
confirmed in CD8+ T cells (supplemental Figure 7A-B), and its expression was sufficient 
to downregulate all let-7 family members except let-7c, which is not subject to control by 
Lin2829 (Figure 6B; supplemental Table 1). Phenotypic analysis of CD8+ T cells from 
chimeric mice revealed that forced expression of Lin28b in adult progenitor cells 
promotes the generation of MP cells that develop after thymic egress, reminiscent of 
neonatal cells (Figure 6C-D; supplemental Figure 7C-D). Notably, in mixed BM 
chimeras, wild-type (WT) CD8+ T cells produced in the same thymus as iLin28b CD8+ 
T cells did not give rise to more MP CD8+ T cells (supplemental Figure 8), suggesting 
that Lin28b drives the development of MP CD8+ T cells in a cell-intrinsic manner.  
To determine whether Lin28b expression influences the fate of CD8+ T cells after 
infection, we adoptively cotransferred equal numbers of WT and iLin28b CD8+ T cells 
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from BM chimeras into adult recipients, and infected the recipients (Figure 6A). The 
data revealed that WT cells predominate as the immune response progressed. The few 
iLin28b CD8+ cells that remained at day 28 responded poorly to secondary challenge, 
and the recall response was entirely comprised of WT cells (Figure 6E). We also 
examined changes in the expression of KLRG1 and CD127 at the peak of the primary 
response, which revealed that most iLin28b cells expressed a SLEC phenotype, 
whereas WT cells exhibited a balance of SLEC and MPEC phenotypes (Figure 6F). 
Together, these data demonstrate that ectopic expression of Lin28b in adult progenitor 
cells enables them to give rise to CD8+ T cells that are phenotypically and functionally 
analogous to those found in neonates, indicating that increased expression of Lin28b in 
neonatal progenitor cells underlies their preferential terminal differentiation into SLECs 
during infection.  
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Figure 2.6. Lin28b reprograms adult CD8+ T cells to behave more like neonatal cells. (A) 
Schematic of experimental design: congenic gBT-I adult (Thy1.1) and iLin28b gBT-I adult 
(Thy1.2) BM cells were transferred into lethally irradiated congenic WT recipient mice (CD45.1) 
separately. Lin28b expression was induced by DOX in drinking water. Eight weeks later, splenic 
donor CD8+ T cells were sorted and adoptively cotransferred into congenic WT recipient mice 
(CD45.1). These recipients were infected with 5×103 WT LM-gB and serially bled to examine 
CD8+ T-cell responses. (B-D) Naïve phenotypes of gBT-I WT or gBT-I iLin28b CD8+ T cells 
before adoptive cotransfer. (B) Expression of miRNAs in adult WT gBT-I and adult iLin28b 
splenic donor CD8+ T cells at 8 weeks after reconstitution. (C) Representative plots showing 
CD44 and CD122 expression by gBT-I BM-derived splenic CD8+ T cells 8 weeks after 
reconstitution. (D) Statistical analysis of the percentages of MP cells from WT gBT-I adult and 
iLin28b adult CD8+ T cells. (E) Relative numbers of iLin28b gBT-I adult (dashed) and WT gBT-I 
adult (solid) BM-derived donor CD8+ T cells postinfection and re-challenge (5×104 WT LM-gB); 
arrows indicate days of infections. (F) Percentages of gBT-I adult and fetal progenitor-derived 
donor CD8+ T cells that are SLECs and MPECs. Data are representative of 2 experiments 
(****P<.0001).  
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Discussion  
Previous work has demonstrated that the ontogeny of the immune system does 
not progress in a linear manner from fetal life to adulthood.30-34 Instead, the prevailing 
model argues that distinct “steps” or “layers” develop sequentially from progenitor cells 
that are metabolically and epigenetically distinct.35-39 As a consequence, unique 
populations of immune cells (B1a-B cells and dendritic epidermal T cells) are generated 
during different windows of development.40-42 In this report, we provide compelling 
support for the existence of a distinct layer of CD8+ T cells that is produced in early life 
and demonstrate that neonatal and adult CD8+ T cells respond differently to infection 
because they are derived from distinct progenitor cells.  
The “layered immune hypothesis” may also be relevant to the ontogeny of MP 
CD8+ T cells. Previous work has suggested that MP cells are driven by lymphopenia-
induced proliferation during early stages of development.22,43 However, our work 
demonstrates that fetal- derived CD8+ T cells preferentially acquire a memory 
phenotype, even when placed in the same environment as adult-derived cells (Figure 
5). These findings suggest that MP cell development cannot be attributed solely to age-
related changes in the environment and indicates that cell-intrinsic differences between 
neonatal and adult CD8+ T cells should also be considered. It will be important to 
determine whether sensitivity to homeostatic cytokines and/or proximity toward IL-7- 
and IL-15- dependent niches in lymphoid tissue is linked to their developmental origin. 
Indeed, perhaps MP cells in young adult mice are derived largely from the fetal layers of 
HSCs.  
Intrathymic transfer experiments allowed us to control for differences in the 
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amount of post-thymic maturation. As recent thymic emigrants (RTEs) make up a larger 
percentage of naïve cells in neonatal mice (100%) compared with adult mice (~10%-
20%)44 and skew toward the short-lived effector lineage after infection,45 there has been 
some speculation that neonatal CD8+ T cells produce fewer memory cells because they 
have yet to undergo a sufficient amount of post-thymic maturation. Although we were 
unable to directly compare neonatal and adult RTEs because of dramatic differences in 
the rates of homeostatic proliferation, it is worth pointing out that we have compared the 
progeny of fetal and adult progenitor cells after giving these cells the same length of 
post-thymic maturation (~4 weeks), and we still observed cell-intrinsic differences 
(Figure 5). Thus, although the age of the cell clearly influences its ability to respond to 
stimulation, the age of the animal in which the cell is created may ultimately be a greater 
determining factor for how a cell will respond after infection.  
What are the molecular mechanisms that underlie the developmental switch from 
fetal to adult CD8+ T-cell production? Our work points toward a role for Lin28b in this 
process, which is highly expressed in fetal animals and then downregulated later in 
development. Previous reports have suggested that many posttranscriptional and 
metabolic differences between fetal and adult HSCs can be attributed to the expression 
of Lin28b.26,46,47 One way in which Lin28b regulates fetal HSCs is by blocking the 
biogenesis of let-7 miRNAs, which control the developmental timing in a wide range of 
species.28,48-51 More recently, let-7 has gained attention for its ability to behave as a 
tumor suppressor in human cancer cells by repressing cell proliferation,52-54 potentially 
by targeting cell cycle factors and genes in the mTOR pathway.9 In this report, we 
demonstrate that ectopic Lin28b expression in adult progenitor cells gives rise to CD8+ 
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T cells that undergo more rapid proliferation and effector cell differentiation (Figure 6). 
To our knowledge, this is the first study demonstrating how Lin28 expression alters the 
CD8+ T-cell response to infection. However, additional studies are required to 
determine the degree to which Lin28b is controlling CD8+ T-cell responses by reducing 
expression of let-7, enhancing the translation of metabolic enzymes55 or other 
factors.56,57 It will be essential to examine more closely the changes in gene expression 
at the individual cell level to uncover the molecular circuitry regulated by Lin28b and let-
7 in CD8+ T cells. We are currently using both gain- and loss-of-function gene targeting 
approaches to identify these networks. Clearly, more work studying the role of let-
7/Lin28 in CD8+ T-cell development is warranted.  
It is intriguing to speculate whether Lin28b was co-opted during the evolution of 
mammalian immune system to serve as rheostat of effector and memory cell 
differentiation during stages of life. A common feature of lymphocytes derived from 
Lin28b1 fetal HSCs is that they tend to respond more rapidly to infection than their adult-
derived counterparts.1,58 Responding with a more vigorous primary CD8+ T cell 
response may help protect the host at critical stages of immune development, but likely 
comes at the cost of not being able to form long- lived memory cells. However, because 
the neonatal CD8+ T-cell repertoire is extremely limited, it is likely that neonatal cells 
are of lesser value in the memory pool, because more “fit” CD8+ T cells will arise later in 
adulthood. Although this model remains to be tested, our data provide insight into the 
developmental-related factors that influence effector and memory CD8+ T-cell 
differentiation during periods of life.  
 
  
 48 
REFERENCES: 
1. Smith NL, Wissink E, Wang J, et al. Rapid proliferation and differentiation impairs 
the development of memory CD8+ T cells in early life. Journal of immunology. 
2014;193(1):177-184. 
2. Reynaldi A, Smith NL, Schlub TE, Venturi V, Rudd BD, Davenport MP. Modeling 
the dynamics of neonatal CD8+ T cell responses. Immunol Cell Biol. 2016. 
3. Wissink EM, Smith NL, Spektor R, Rudd BD, Grimson A. MicroRNAs and Their 
Targets Are Differentially Regulated in Adult and Neonatal Mouse CD8+ T Cells. 
Genetics. 2015;201(3):1017-1030. 
4. Takada K, Jameson SC. Naive T cell homeostasis: from awareness of space to a 
sense of place. Nature reviews Immunology. 2009;9(12):823-832. 
5. Surh CD, Sprent J. Homeostasis of naive and memory T cells. Immunity. 
2008;29(6):848-862. 
6. Bowie MB, McKnight KD, Kent DG, McCaffrey L, Hoodless PA, Eaves CJ. 
Hematopoietic stem cells proliferate until after birth and show a reversible phase-
specific engraftment defect. The Journal of clinical investigation. 
2006;116(10):2808-2816. 
7. Barber CL, Montecino-Rodriguez E, Dorshkind K. Reduced production of B-1-
specified common lymphoid progenitors results in diminished potential of adult 
marrow to generate B-1 cells. Proc Natl Acad Sci U S A. 2011;108(33):13700-
13704. 
8. Mueller SN, Heath W, McLain JD, Carbone FR, Jones CM. Characterization of 
two TCR transgenic mouse lines specific for herpes simplex virus. Immunol Cell 
Biol. 2002;80(2):156-163. 
9. Zhu H, Shyh-Chang N, Segre AV, et al. The Lin28/let-7 axis regulates glucose 
metabolism. Cell. 2011;147(1):81-94. 
10. Adkins B. Developmental regulation of the intrathymic T cell precursor 
population. J Immunol. 1991;146(5):1387-1393. 
  
 49 
11. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with 
RNA-Seq. Bioinformatics. 2009;25(9):1105-1111. 
12. Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L. 
Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat 
Biotechnol. 2013;31(1):46-53. 
13. Friedlander MR, Chen W, Adamidi C, et al. Discovering microRNAs from deep 
sequencing data using miRDeep. Nat Biotechnol. 2008;26(4):407-415. 
14. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient 
alignment of short DNA sequences to the human genome. Genome Biol. 
2009;10(3):R25. 
15. Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional 
genomics data sets--update. Nucleic Acids Res. 2013;41(Database issue):D991-
995. 
16. Reynolds AP, G. Richards, B. de la Iglesia, , V. J. Rayward-Smith. . Clustering 
Rules: A Comparison of Partitioning and Hierarchical Clustering Algorithms. 
Journal of Mathematical Modelling and Algorithms;5(4):475-504. 
17. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of 
large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44-
57. 
18. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths 
toward the comprehensive functional analysis of large gene lists. Nucleic Acids 
Res. 2009;37(1):1-13. 
19. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a 
knowledge-based approach for interpreting genome-wide expression profiles. 
Proc Natl Acad Sci U S A. 2005;102(43):15545-15550. 
20. Goldrath AW, Bogatzki LY, Bevan MJ. Naive T cells transiently acquire a 
memory-like phenotype during homeostasis-driven proliferation. J Exp Med. 
2000;192(4):557-564. 
21. Kieper WC, Jameson SC. Homeostatic expansion and phenotypic conversion of 
  
 50 
naive T cells in response to self peptide/MHC ligands. Proc Natl Acad Sci U S A. 
1999;96(23):13306-13311. 
22. Min B, McHugh R, Sempowski GD, Mackall C, Foucras G, Paul WE. Neonates 
support lymphopenia-induced proliferation. Immunity. 2003;18(1):131-140. 
23. Schonland SO, Zimmer JK, Lopez-Benitez CM, et al. Homeostatic control of T-
cell generation in neonates. Blood. 2003;102(4):1428-1434. 
24. Goldrath AW, Luckey CJ, Park R, Benoist C, Mathis D. The molecular program 
induced in T cells undergoing homeostatic proliferation. Proc Natl Acad Sci U S 
A. 2004;101(48):16885-16890. 
25. Kaech SM, Hemby S, Kersh E, Ahmed R. Molecular and functional profiling of 
memory CD8 T cell differentiation. Cell. 2002;111(6):837-851. 
26. Thornton JE, Gregory RI. How does Lin28 let-7 control development and 
disease? Trends Cell Biol. 2012;22(9):474-482. 
27. Jiang S, Baltimore D. RNA-binding protein Lin28 in cancer and immunity. Cancer 
Lett. 2016;375(1):108-113. 
28. Yuan J, Nguyen CK, Liu X, Kanellopoulou C, Muljo SA. Lin28b reprograms adult 
bone marrow hematopoietic progenitors to mediate fetal-like lymphopoiesis. 
Science. 2012;335(6073):1195-1200. 
29. Triboulet R, Pirouz M, Gregory RI. A Single Let-7 MicroRNA Bypasses LIN28-
Mediated Repression. Cell Rep. 2015;13(2):260-266. 
30. Krow-Lucal ER, McCune JM. Distinct functional programs in fetal T and myeloid 
lineages. Front Immunol. 2014;5:314. 
31. Krow-Lucal ER, Kim CC, Burt TD, McCune JM. Distinct functional programming 
of human fetal and adult monocytes. Blood. 2014;123(12):1897-1904. 
32. Mold JE, McCune JM. At the crossroads between tolerance and aggression: 
Revisiting the "layered immune system" hypothesis. Chimerism. 2011;2(2):35-41. 
  
 51 
33. Mold JE, Venkatasubrahmanyam S, Burt TD, et al. Fetal and adult hematopoietic 
stem cells give rise to distinct T cell lineages in humans. Science. 
2010;330(6011):1695-1699. 
34. Mold JE, Michaelsson J, Burt TD, et al. Maternal alloantigens promote the 
development of tolerogenic fetal regulatory T cells in utero. Science. 
2008;322(5907):1562-1565. 
35. Kim I, Saunders TL, Morrison SJ. Sox17 dependence distinguishes the 
transcriptional regulation of fetal from adult hematopoietic stem cells. Cell. 
2007;130(3):470-483. 
36. Mochizuki-Kashio M, Mishima Y, Miyagi S, et al. Dependency on the polycomb 
gene Ezh2 distinguishes fetal from adult hematopoietic stem cells. Blood. 
2011;118(25):6553-6561. 
37. Park IK, Qian D, Kiel M, et al. Bmi-1 is required for maintenance of adult self-
renewing haematopoietic stem cells. Nature. 2003;423(6937):302-305. 
38. Hock H, Hamblen MJ, Rooke HM, et al. Gfi-1 restricts proliferation and preserves 
functional integrity of haematopoietic stem cells. Nature. 2004;431(7011):1002-
1007. 
39. Hock H, Meade E, Medeiros S, et al. Tel/Etv6 is an essential and selective 
regulator of adult hematopoietic stem cell survival. Genes Dev. 
2004;18(19):2336-2341. 
40. Havran WL, Allison JP. Origin of Thy-1+ dendritic epidermal cells of adult mice 
from fetal thymic precursors. Nature. 1990;344(6261):68-70. 
41. Havran WL, Allison JP. Developmentally ordered appearance of thymocytes 
expressing different T-cell antigen receptors. Nature. 1988;335(6189):443-445. 
42. Hayakawa K, Hardy RR, Herzenberg LA, Herzenberg LA. Progenitors for Ly-1 B 
cells are distinct from progenitors for other B cells. J Exp Med. 1985;161(6):1554-
1568. 
43. Akue AD, Lee JY, Jameson SC. Derivation and maintenance of virtual memory 
CD8 T cells. J Immunol. 2012;188(6):2516-2523. 
  
 52 
44. Fink PJ. The biology of recent thymic emigrants. Annu Rev Immunol. 
2013;31:31-50. 
45. Makaroff LE, Hendricks DW, Niec RE, Fink PJ. Postthymic maturation influences 
the CD8 T cell response to antigen. Proc Natl Acad Sci U S A. 
2009;106(12):4799-4804. 
46. Shyh-Chang N, Daley GQ. Lin28: primal regulator of growth and metabolism in 
stem cells. Cell Stem Cell. 2013;12(4):395-406. 
47. Copley MR, Babovic S, Benz C, et al. The Lin28b-let-7-Hmga2 axis determines 
the higher self-renewal potential of fetal haematopoietic stem cells. Nat Cell Biol. 
2013;15(8):916-925. 
48. Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates 
developmental timing in Caenorhabditis elegans. Nature. 2000;403(6772):901-
906. 
49. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel 
genes coding for small expressed RNAs. Science. 2001;294(5543):853-858. 
50. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of 
mammalian microRNA host genes and transcription units. Genome Res. 
2004;14(10A):1902-1910. 
51. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal 
development and disease. Dev Cell. 2006;11(4):441-450. 
52. Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let-7 
microRNAs in human lung cancers in association with shortened postoperative 
survival. Cancer research. 2004;64(11):3753-3756. 
53. Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S. Role of Dicer and Drosha for 
endothelial microRNA expression and angiogenesis. Circ Res. 2007;101(1):59-
68. 
54. Barh D, Malhotra R, Ravi B, Sindhurani P. MicroRNA let-7: an emerging next-
generation cancer therapeutic. Curr Oncol. 2010;17(1):70-80. 
  
 53 
55. Shyh-Chang N, Zhu H, Yvanka de Soysa T, et al. Lin28 enhances tissue repair 
by reprogramming cellular metabolism. Cell. 2013;155(4):778-792. 
56. Wilbert ML, Huelga SC, Kapeli K, et al. LIN28 binds messenger RNAs at GGAGA 
motifs and regulates splicing factor abundance. Mol Cell. 2012;48(2):195-206. 
57. Zeng Y, Yao B, Shin J, et al. Lin28A Binds Active Promoters and Recruits Tet1 to 
Regulate Gene Expression. Mol Cell. 2016;61(1):153-160. 
58. Montecino-Rodriguez E, Dorshkind K. New perspectives in B-1 B cell 
development and function. Trends Immunol. 2006;27(9):428-433. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 54 
SUPPLEMENTARY FIGURES: 
 
Figure 2.S1.  Naïve CD8+ T cells acquire a memory phenotype in the periphery during 
early life.  Percentages of thymic (A) and splenic (B) CD8+ T cells from uninfected gBT-I mice 
that exhibit a memory phenotype (MP, CD44hi CD122hi) at various ages. (C) Relative number of 
splenic CD8+ T cells that are actively proliferating (Ki-67 positive) in different aged gBT-I mice.  
Data are representative of 2 experiments. 
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Figure 2.S2. Gene loadings for principal component analysis. The values for all genes 
corresponding to the samples used in Figure 2A are shown. Values on the x-axis correspond to 
the placement of samples on the x-axis; the same is true for the y-axis. In red are the genes 
with the highest or lowest values for PC1 and PC2, demonstrating they had the largest effect on 
the PCA. 
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Figure 2.S3. Differential gene expression between neonatal and adult CD8+ splenocytes 
and thymocytes measured by flow cytometry. Flow cytometry analysis of CD8-enriched 
splenocytes (A-B) and bulk thymocytes (C-D) from neonatal (line) and adult (shaded) animals. 
Representative histograms shown in A, C, and geometric mean fluorescent intensities depicted 
in B, D; n=3-5 mice/group. Significance was assessed by student t-test; *P < .05, **P < .01, ***P 
< .001, ****P < .0001. 
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Figure 2.S4. Gene loadings for principal component analysis. The values for all genes 
corresponding to the samples used in Figure 4A are shown. Values on the x-axis correspond to 
the placement of samples on the x-axis; the same is true for the y-axis. In red are the genes 
with the highest or lowest values for PC1 and PC2, demonstrating they had the largest effect on 
the PCA. 
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Figure 2.S5. Neonatal CD8+ thymocytes proliferate more than their adult counterparts 
following in vitro stimulation.  Single positive CD8+ thymocytes from gBT-I adult (shaded) 
and neonatal (line) mice were labeled with CFSE and stimulated with plate-bound anti-CD3/anti-
CD28. Data is representative of 2 experiments. 
 
 
Figure 2.S6. Double-negative thymocytes preferentially express Lin28b in fetal life.  RNA 
was isolated from double negative (DN) thymocytes obtained from fetal and adult gBT-I mice 
and the relative amount of Lin28b was examined by qPCR.  
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Figure 2.S7.  Upregulation of Lin28b does not result in more memory phenotype cells in 
the thymus. (A) Representative flow cytometry data showing levels of human Lin28b in WT 
(shaded histogram) and iLin28b (open histogram) CD8+ T cells from the spleen and thymus of 
chimeric mice, and (B) percentages of Lin28b+ cells. Also depicted are representative plots (C) 
showing CD44 and CD122 expression in thymic CD8+ T cells, and (D) percentages of MP cells. 
Data is representative of 2 experiments. 
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Figure 2.S8. Lin28b reprograms adult CD8+ T cells in a cell-intrinsic manner. (A) 
Schematic of experimental design: congenic gBT-I adult (Thy1.1) and iLin28b gBT-I adult 
(Thy1.2) bone marrow cells were co-transferred into the same lethally irradiated congenic WT 
recipient mice (CD45.1). Lin28b expression was induced by DOX in drinking water. 8 weeks 
later, bone marrow-derived splenic CD8+ T cells were sorted and adoptively co-transferred into 
congenic WT recipient mice (CD45.1).  These recipients were infected with 5 × 103 WT LM-gB 
and serially bled to examine CD8+ T cell responses.  (B-C) Naïve phenotypes of gBT-I WT and 
gBT-I iLin28b CD8+ T cells prior to adoptive co-transfer. (B) Representative plots showing 
CD44 and CD122 expression by gBT-I bone marrow-derived splenic CD8+ T cells, and (C) 
percentages of MP cells. (D) Relative numbers of iLin28b gBT-I adult (dashed) and WT gBT-I 
adult (solid) bone marrow-derived donor CD8+ T cells post infection and re-challenge (5 × 104 
WT LM-gB); arrows indicate days of infections. (E) Percentages of WT gBT-I adult and iLin28b 
gBT-I adult CD8+ T cells that are SLECs and MPECs at 7dpi; *P < .05, ****P < .0001. 
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CHAPTER THREE 
Adult and neonatal CD8+ T cells utilize different metabolism programs 
SUMMARY 
CD8+ T cells from neonatal and adult mice respond differently to infection. Upon 
activation, neonatal CD8+ T cells rapidly become more terminal differentiated and 
undergo more contraction than adult CD8+ T cells following pathogen clearance. 
However, the underlying mechanisms contributing to these differences are unclear. 
Historically, metabolic programs have been known to regulate a diverse array of cellular 
functions. In recent years, metabolism has become an intense area of investigation by 
immunologists and many studies have revealed the importance of different metabolic 
programs in T cell activation and differentiation. In this study, we show that neonatal 
CD8+ T cells acquire a more metabolically active status after stimulation, demonstrated 
by less OXPHOS and more glycolytic activities. We also found that the impaired 
development of neonatal memory CD8+ T cells could be rescued by limiting mTOR, 
which may be elevated in neonatal CD8+ T cell because of age-related differences in 
Lin28b expression. Collectively, our data suggest that neonatal CD8+ T cells 
preferentially become short-lived effector cells after infection because they exhibit an 
inherently more metabolically active program after antigenic stimulation.    
INTRODUCTION 
Neonates are more susceptible to repeated infections from the same intracellular 
pathogen because they exhibit insufficient immunological memory formation. CD8+ T 
cells are critical in eliminating intracellular pathogens from the hosts. Hence, it is 
important to gain insight into why neonatal CD8+ T cells respond differently to infections 
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than adults. Recent studies suggest that neonatal CD8+ T cells fail to form sufficient 
memory because they proliferate rapidly and quickly become terminal differentiated 
post-activation1–3. Neonatal and adult CD8+ T cells display these age-related 
differences because they are derived from distinct progenitor cells1. However, the 
underlying mechanisms that regulate these age-related different behaviors in CD8+ T 
cells are unknown.  
The role of metabolic pathways in T cells was largely overlooked until recently. In 
the past few years, a tremendous amount of studies have demonstrated the critical 
regulatory role of metabolic programs in T cell response. Currently, the common notion 
in the field is that CD8+ T cells utilize different metabolic programs upon activation4,5. 
Naïve CD8+ T cells prefer using high ATP producing oxidative phosphorylation 
(OXPHOS) as their major energy source. Upon activation, OXPHOS is still utilized6. 
However, in order to meet the high demand of extensive proliferation, CD8+ T cells 
prefer to use catabolic glycolysis to provide sufficient building units to construct progeny 
cells4,5,7. This is a phenomena known as “Warburg Effect” that has been shown to be 
particularly important in rapidly proliferating cells8. In order to survive and differentiate 
into memory cells, CD8+ T cells need to acquire a more quiescent metabolic prolife by 
utilizing pathways like OXPHOS and fatty acid oxidation (FAO) to support their 
survival4,7,9–11. Since neonatal CD8+ T cells proliferate rapidly and fail to form sufficient 
memory post-activation, we hypothesize that neonatal CD8+ T cells preferably use a 
excessively active metabolic program upon activation, which results in a failure to 
acquire a more quiescent metabolic prolife needed to make memory cells.  
To address this question, we measured the metabolic activities in different aged 
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CD8+ T cells post-infections. We found that neonatal CD8+ T cells demonstrated lower 
OXPHOS and higher glycolytic activities post-infection, which is consistent with our 
hypothesis. mTOR pathway is heavily involved with cellular metabolism and has been 
shown to regulate CD8+ T cell differentiation12–14. Hence, we limited mTOR activities to 
assess its role in regulating metabolic programs in neonatal CD8+ T cells and found that 
limiting mTOR allowed neonatal cells to behave more analogously to adult cells.  
Moreover, our data suggest that Lin28b may regulate CD8+ T behaviors through 
mTOR, implicating mTOR as a key regulator driving age-related differences in the CD8+ 
T cell response to infection.  
MATERIAL AND METHODS  
Mice 
B6-Ly5.2/Cr mice were purchased from Charles River Laboratories (Frederick, 
MD). TCR transgenic mice specific for the HSV-1 glycoprotein B498-505 peptide 
SSIEFARL8 (gBT-I mice) were provided by Janko Nikolich-Zugich (University of 
Arizona, Tucson, AZ) and crossed with Thy1.1 or C57BL/6 mice purchased from 
Jackson Laboratories (Bar Harbor, ME). Neonatal and adult gBT-I animals were used at 
5 to 7 days old and at 2 to 4 months old, respectively. Mice with a tetracycline-inducible 
copy of human LIN28B on a C57BL/6 background (iLin28b mice) were obtained from 
George Daley (Harvard University, Cambridge, MA)15. Mice were housed under specific 
pathogen-free conditions at Cornell University College of Veterinary Medicine, 
accredited by the Assessment and Accreditation of Laboratory Animal Care.  
Antibodies and flow cytofluorimetric analysis  
Antibodies were purchased from eBioscience (San Diego, CA), Biolegend (San 
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Diego, CA), Invitrogen (Carlsbad, CA), or BD Biosciences (Mountain View, CA). Flow 
cytofluorimetric data were acquired using DiVa software from an LSRII equipped with 4 
lasers (BD Biosciences). Analysis was performed with FlowJo (Tree Star, Ashland, OR).  
BM chimeras 
Single BM chimeras were generated by obtaining BM from congenically marked 
gBT-I (Thy1.1+CD45.2+) and gBT-I iLin28b (Thy1.2+CD45.2+) mice. CD4+ and CD8+ 
BM cells were depleted by magnetic separation, and 1×107 cells were injected into 
lethally irradiated (990 rads) 7- to 8-week-old adult B6-Ly5.2 recipients. Forty-eight 
hours posttransplantation, mice were administered 0.1 mg/ml doxycycline with 10 mg/ml 
sucrose via drinking water to induce LIN28B expression for 6-8 weeks during 
reconstitution.  
Adoptive transfer 
Microbeads (Miltenyi Biotec) enriched gBT-I splenic neonatal and adult CD8+ 
cells, or FACS-sorted CD8+ cells from BM chimeras were combined at a 1:1 ratio. 
Combined cells were suspended at 5×105 cells per ml of PBS and 100 ul of cells was 
injected i.v. into adult B6-Ly5.2 recipient mice. The next day, recipient mice were 
infected with WT LM-gB (5×103 CFU, i.v.), as described.2 For adoptive transfers in the 
presence of rapamycin, rapamycin (LC Laboratories or Chemie Tek) was given at 100 
ng/g i.p. daily from 0-7 dpi.  
Cell sorting 
To purify CD8+ T cells from adoptive cotransfer recipient mice to perform cellular 
metabolism analysis (Agilent Seahorse), CD8+ T cells were enriched using microbeads 
(Miltenyi Biotec) and were subsequently labeled with antibodies against CD8, CD45.1, 
  
 65 
CD45.2 and Thy1.1 and sorted to >95% purity on a fluorescence-activated cell sorting 
(FACS) Aria III (BD Biosciences). To isolate CD8+ T cells from chimeric mice, CD4+, 
CD19+, MHC-II+, and Ter119+ cells were depleted by negative immunomagnetic 
selection1. Cells were labeled with antibodies against CD8, CD45.1, CD45.2 and Thy1.1 
and FACS-sorted to >95% purity for adoptive cotransfers. Two additional antibodies 
against CD127 and KLRG1 were used when sorting on SLEC populations from the 
donor cell groups.  
Metabolism assays 
3×105 cells plated in buffer-free media with 2 mM glutamine ± 25 mM glucose 
and ± 1 mM sodium pyruvate were used to measure oxygen consumption rates (OCR, 
with glucose and sodium pyruvate) or extra-cellular acidification rates (ECAR, no 
glucose and sodium pyruvate) using XFp Extracellular Flux Analyzer (Agilent 
Seahorse). OCR was measured following the addition of 1 uM oligomycin, 1 uM FCCP 
and 0.5 uM rotenone/antimycin A. ECAR was measured following the addition of 10 mM 
glucose, 1 uM oligomycin and 50 uM 2-Deoxy-D-glucose (2DG).  
In vitro stimulation and proliferation 
Cells were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE), 
as described2, and cells were stimulated with plate-bound anti-CD3 (5 mg/ml) and anti-
CD28 (20 mg/ml).  
Statistical analysis  
Statistical analysis was performed using Prism (GraphPad Software, Inc, La 
Jolla, CA). Error bars represent standard error of the mean. Significance was 
determined by Student t test. Significance is denoted as: *P < .05, **P <  .01, ***P <  
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.001, and ****P < .0001.  
RESULTS 
Naïve adult and neonatal utilize different metabolic programs 
First, we wanted to examine the metabolic programs utilized by naïve CD8+ T 
cells collected at different ages. Naïve CD8+ T cells were sorted from both 7-day-old 
neonate and 2-3 month old adult gBT-I mice to measure their oxygen consumption rate 
(OCR) and extracellular acidification rate (ECAR), which are indicators of OXPHOS and 
glycolytic activities, respectively. Surprisingly, naïve neonatal CD8+ T cells 
demonstrated higher basal and maximal OCR than naïve adult CD8+ T cells (Figure 1A 
and 1B), indicating higher OXPHOS activity in naïve CD8+ T cells. Naïve neonatal 
CD8+ T cells also have slightly higher spare respiratory capacity (SRC, difference 
between maximal and basal OCR) (Figure 1B). SRC is an indicator of how much extra 
capacity mitochondria have to provide energy upon increased demand. It has been 
shown to be positively correlated with memory T cell formation10. Naïve neonatal CD8+ 
T cells also exhibited lower basal and maximal ECAR than adult CD8+ T cells (Figure 
1C and 1D), suggesting lower glycolytic activity in naïve neonatal CD8+ T cells. These 
differences could be attributed to the higher percentage of CD122+ (IL15 receptor) cells 
in naïve neonatal CD8+ T cells1. IL15 has been shown to promote mitochondrial 
biogenesis, which can result in higher OXPHOS level10. Collectively, our data suggest 
that neonatal CD8+ T cells display higher OXPHOS and lower glycolytic activities prior 
to infection.  
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Figure 3.1. Naïve neonatal CD8+ T cells demonstrate higher OXPHOS and lower 
glycolytic activities compare to adult. (A) OCR measurements of sorted naïve adult and 
neonatal CD8+ T cells. (B) Statistical analysis of basal, max OCR and SRC of naïve adult and 
neonatal CD8+ T cells. (C) ECAR measurements of sorted naïve adult and neonatal CD8+ T 
cells. (D) Statistical analysis of basal and max ECAR of naïve adult and neonatal CD8+ T cells. 
Data are representative of 2 experiments. Significance was determined by student t test. **P < 
.01. 
 
Neonatal CD8+ T cells demonstrate higher metabolic activities post-activation in 
vitro 
Neonatal CD8+ T cells can undergo vigorous proliferation and quickly become 
terminal differentiated post-activation, which we hypothesize require support from more 
active catabolic pathways based on previous studies4,5. In an effort to uncover the 
specific metabolic program utilized by each age group, we first performed quantitive 
PCR on glycolytic proteins in adult and neonatal gBT-I CD8+ T cells collected at 8-hour 
post in vitro stimulation (Figure 2). Glut1 encodes glucose transporter, which is very 
critical in managing glucose uptake. Mutation in Glut1 can result in systemic disorders16. 
HK2 is one of the glycolytic enzymes we examined, and it encodes hexokinase 2, which 
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mediates the first step in glucose metabolism and has been shown to be up-regulated in 
cancer cells with Warburg Effect17. GPI, TPI and LDHa are other glycolytic enzymes we 
examined (Figure 2). MCT encodes another transporter transferring lactate outside of 
the cell membrane18. We found that the mRNA of all the major components and 
enzymes involved in glycolysis were highly up-regulation post-activation in neonatal 
CD8+ T cells, which indicate that neonatal CD8+ T cells have the potential to launch a 
more metabolic active program upon stimulation.  
We then investigated how metabolites from major pathways are regulated post-
activation. We performed liquid chromatography/tandem mass spectrometry based 
metabolomics on adult and neonatal gBT-I CD8+ T cells to profile their metabolites post 
in vitro stimulation at 18-hour (Figure 3). We found that activated neonatal CD8+ T cells 
demonstrated higher level of most of the intermediate metabolites in glycolysis (Figure 
3). In contrast, the metabolites involved in OXPHOS (TCA cycle) were not significantly 
different in neonatal and adult CD8+ T cells, implying that OXPHOS activity either 
preferentially increased in adults cells or decreased in neonatal cells following activation 
(Figure 1 and 3).   
Collectively, our data suggest that neonatal CD8+ T cells could quickly acquire a 
more metabolic active profile compare to their adult counterparts upon activation.  
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Figure 3.2. mRNA of glycolytic proteins are up-regulated in neonatal CD8+ T cells post-
activation in vitro. mRNA level of several important proteins were measured using quantative 
PCR at 8-hour post plate bound αCD3/CD28 stimulation. Significance was determined by 
student t test. *P < .05. 
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Figure 3.3. Metabolomics measurements of metabolites in OXPHOS and glycolytic 
pathways post-activation in vitro. Metabolomics was performed on adult and neonatal gBT-I 
CD8+ T cells 18-hour post-activation in vitro. Data has been normalized to measurements 
collected at naïve stage. Significance was determined by student t test. *P < .05 and **P < .01. 
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Figure 3.4. Infected neonatal CD8+ T cells have higher glycolytic and lower OXPHOS 
activities prior to the peak of response. (A) SLEC populations of adult and neonatal CD8+ T 
cells on 5 and 7 dpi. (B) Ratios of adult to neonatal CD8+ T cells on 5 and 7 dpi. (C) Schematic 
of experimental design: adoptively co-transferred adult and neonatal CD8+ T cells were sorted 
for metabolic analysis. (D) OCR measurements of 5 dpi adult and neonatal CD8+ T cells. (E) 
Statistical analysis of basal, max OCR and SRC of adult and neonatal CD8+ T cells on 5 dpi. 
(F) ECAR measurements of 5 dpi adult and neonatal CD8+ T cells. (G) Statistical analysis of 
basal and max ECAR of 5 dpi adult and neonatal CD8+ T cells. Data are representative of 2 
experiments. Significance was determined by student t test. *P < .05.   
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Neonatal CD8+ T cells acquire a less quiescent program upon infection 
Next, we wanted to assess the metabolic changes in different aged CD8+ T cells 
upon infection directly. We first assessed different aged CD8+ T cell responses upon 
listeria monocytogenes-gB (LM-gB) infection. Consistent with previously studies2, 
neonatal CD8+ T cells quickly became more terminal differentiated and contract more 
rapidly than adult CD8+ T cells post-infection. Neonatal CD8+ T cells have higher 
percentages of more terminally differentiated short-lived effector precursors (SLECs, 
KLRG1+CD127-) on 5 and 7 days post infection (dpi) than their adult counterparts 
(Figure 4A). Adult to neonatal CD8+ T cells ratios increased post-infection, indicating 
that neonatal CD8+ T cells peak sooner than adults within the same period post-
infection (Figure 4B). Adoptively co-transferred adult and neonatal CD8+ T cells were 
sorted back out on 5 and 7 dpi to measure their metabolic activities (Figure 4C). Early 
after infection, neonatal CD8+ T cells started to have lower OXPHOS activities indicated 
by lower basal and maximal OCR measurements compared to adults on 5 dpi (Figure 
4D and 4E). Neonatal CD8+ T cells also showed lower SRC than adults (Figure 4E). 
Lower neonatal SRC implied that they have lower memory formation potential, which is 
consistent with previous findings2. Glycolytic activity in neonatal CD8+ T cells also 
started to increase on 5 dpi, indicated by higher basal ECAR (Figure 4F and 4G).  
On 7 dpi, the adult peak of response post-infection, the differences in metabolic 
programs between different aged CD8+ T cells became more drastic (Figure 5). 
Neonatal CD8+ T cells showed significantly higher basal and maximal OCR than adult 
CD8+ T cells, suggesting higher OXPHOS activity in neonatal CD8+ T cells (Figure 5A 
and 5B). Neonatal CD8+ T cells exhibited much lower SRC than their adult counterparts 
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(Figure 5B), which implies that as infection progresses neonatal CD8+ T cells quickly 
lose their potential to form memory cells. Basal and maximal ECAR also increased 
significantly in neonatal CD8+ T cells, indicating neonatal T cells utilize a lot more 
glycolysis at the peak of infection (Figure 5C and 5D). Overall, our data showed that 
upon infection, neonatal CD8+ T cells preferably using glycolysis more than OXPHOS 
and quickly lose memory forming potential. This is consistent with previously shown 
rapid proliferation and quick terminal differentiation in activated neonatal CD8+ T cells. 
 
Figure 3.5. Infected neonatal CD8+ T cells have higher glycolytic and lower OXPHOS 
activities at the peak of response. (A) OCR measurements of 7 dpi adult and neonatal CD8+ 
T cells. (B) Statistical analysis of basal, max OCR and SRC of adult and neonatal CD8+ T cells 
on 7 dpi. (C) ECAR measurements of 7 dpi adult and neonatal CD8+ T cells. (D) Statistical 
analysis of basal and max ECAR of 7 dpi adult and neonatal CD8+ T cells. Data are 
representative of 2 experiments. Significance was determined by student t test. *P < .05, **P < 
.01, and ***P < .001. 
 
Neonatal and adult effector precursors utilize different metabolic programs 
Neonatal CD8+ T cells exhibit a higher percentage of terminally differentiated 
SLECs than adult CD8+ T cells. In order to test whether the more active metabolic 
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program (lower OXPHOS and higher glycolytic) in neonatal donor CD8+ T cells can be 
explained by the higher amount of SLECs, KLRG1+CD127- CD8+ T cells were sorted 
from recipient mice on 7 dpi and cell numbers were normalized to compare their 
metabolic activities (Figure 6A, B). Interestingly, neonatal CD8+ T cells still showed 
higher OXPHOS activity demonstrated by higher basal and maximal OCR (Figure 6C 
and 6D).  Neonatal SLECs displayed lower SRC compared with adult SLECs 
suggesting lower memory forming potential (Figure 6D). The basal ECAR also 
increased in neonatal SLEC cells indicating higher glycolytic activity (Figure 6E and 6F). 
These findings are consistent with the observed metabolic differences in bulk adult and 
neonatal CD8+ T cells (Figure 4 and 5). Thus, the more metabolic active program 
observed in neonatal donor CD8+ T cells upon infection does not appear to be due to 
the higher percentage of more terminal differentiated SLECs at the peak of the 
response, but instead because they are intrinsically different than adult CD8+ T cells. 
Lin28b regulates CD8+ T cell development through mTOR 
Previously, we have shown that Lin28b plays an important role in regulating the 
neonatal CD8+ T cell response1. Lin28b is highly expressed in early life and plays an 
important role in fetal hematopoiesis19,20. When Lin28b is overexpressed in adult CD8+ 
T cells, they can acquire a neonatal CD8+ T cell phenotype and become more terminal 
differentiated post-infection1. Lin28b can also promote proliferation in adult gBT-I CD8+ 
T cells upon in vitro stimulation compare to wild type (WT) adult gBT-I CD8+ T cells 
(Figure 7A).  
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Figure 3.6. Neonatal SLEC CD8+ T cells have higher glycolytic and lower OXPHOS 
activities at the peak of response. (A) Schematic of experimental design: SLEC populations 
from adoptively co-transferred adult and neonatal CD8+ T cells were sorted for metabolic 
analysis. (B) Gating strategy of adult and neonatal SLECs (KLRG1+CD127-). (C) OCR 
measurements of 7 dpi adult and neonatal SLEC CD8+ T cells. (B) Statistical analysis of basal, 
max OCR and SRC of SLEC adult and neonatal CD8+ T cells. (C) ECAR measurements of 7 
dpi adult and neonatal SLEC CD8+ T cells. (D) Statistical analysis of basal, max ECAR and 
glycolysis reserve of SLEC adult and neonatal CD8+ T cells. Significance was determined by 
student t test, *P < .05 and **P < .01.  
 
However, the mechanism of how Lin28b influences the fate of CD8+ T cells after 
infection still remains unclear. Mammalian target of rapamycin (mTOR) is one of the 
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proposed targets of Lin28, and recent data has indicated that mTOR is a major 
regulator in CD8+ T cell metabolism and function13,21–23. Lin28 has been proposed to 
promote mTOR activities which lead to increased glycolysis15. Here, we wanted to 
assess whether the impact of Lin28b in adult CD8+ T cells is mediated by mTOR 
activity. To do that, we utilized the same doxycycline-inducible Lin28b mouse model as 
described before1. We induced Lin28b expression in adult gBT-I CD8+ T cells (iLin28b) 
and compared their behaviors with WT adult CD8+ T cells. WT and iLin28b adult CD8+ 
T cells were adoptively co-transferred into the same recipients. Rapamycin or PBS was 
given daily for 7 days post-infection (Figure 7B). Consistent with previous study, adult 
CD8+ T cells with ectopic expression of Lin28b responded to infection in a more 
neonatal-like manner with more rapid contraction and insufficient memory formation 
(Figure 7C, left panel). Interestingly, in the presence of rapamycin, iLin28b adult CD8+ T 
cells formed similar level secondary response post-challenge as their WT adult 
counterparts, which suggest that limiting mTOR activities in CD8+ T cells can rescue 
the impaired development of Lin28b-induced CD8+ T cells (Figure 7C, right panel). This 
data is consistent with previous reports indicating that mTOR is a downstream target of 
Lin2815,24,25.  We also examined how rapamycin influences the kinetics and phenotype 
of adult CD8+ T cells induced with Lin28b.  In line with previous observations, we found 
that Lin28b promotes terminal differentiation of effector CD8+ T cells and limited their 
ability to transition into the long-lived memory pool.  However, in the presence of 
rapamycin, Lin28b-induced cells appear more phenotypically similar to wild-type cells 
(Figure 7D).  Also, limiting mTOR rescued the ability of Lin28b-induced CD8+ T cells to 
form memory CD8+ T cells (Figure 7E).  These data suggested that rapamycin 
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promotes development of Lin28b-induced memory CD8+ T cells by limiting terminal 
differentiation and enhancing survival during contraction.  
 
Figure 3.7. Lin28b regulates CD8+ T cell development through mTOR. (A) Overexpressing 
Lin28b promote proliferation in adult CD8+ T cells in vitro at 68 hour post-stimulation. (B) 
Experimental design: WT and iLin28b gBT-I CD8+ T cells were sorted from bone marrow 
chimera and adoptively co-transferred into recipients for serial bleed. PBS or rapamycin were 
given I.P. post-LmgB infection for 7 days. (C) SLEC populations of WT and iLin28b adult CD8+ 
T cells with and without rapamycin on 7 dpi. (D) Cell number of of WT and iLin28b adult CD8+ T 
cells with and without rapamycin on 21 dpi. Data are representative of 2 experiments. 
Significance was determined by student t test. *P < .05 and ****P < .0001. 
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Figure 3.8. Limiting mTOR activities improve neonatal CD8+ T cells survival and alter 
their metabolism. (A) Schematic of experimental design: adoptively co-transferred adult and 
neonatal CD8+ T cells in the presence or absence of rapamycin were bled or sorted for 
metabolic analysis. (B) SLEC populations of different groups with and without rapamycin. (C) 
CD8+ T cell number of different groups with and without rapamycin on 25 dpi. (D) OCR 
measurements of 7 dpi neonatal control and neonatal+rapamycin CD8+ T cells. (E) Statistical 
analysis of basal, max OCR and SRC of (D). (F) ECAR measurements of 7 dpi neonatal control 
and neonatal+rapamycin CD8+ T cells. (G) Statistical analysis of basal, max ECAR and 
glycolysis reserve of (F). Data are representative of 2 experiments. Significance was determined 
by student t test. *P < .05, **P < .01, and ****P < .0001.  
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Limiting mTOR activities improve neonatal CD8+ T cells survival and alter their 
metabolism 
Up to this point, we have showed that different aged CD8+ T cells utilize different 
metabolic programs post-infection, and Lin28b potentially regulate CD8+ T cells 
responses through mTOR. However, the role of mTOR and Lin28b in CD8+ T cells were 
restricted to adult CD8+ T cells.  Thus, a key remaining question is whether we can 
make neonatal CD8+ T cells behave more similarly to adult CD8+ T cells by 
manipulating mTOR or their metabolic activities. 
To investigate the link between mTOR and metabolism in neonatal CD8+ T cells, 
we first used rapamycin to limit mTOR activity in different aged CD8+ T cells post-
infection in adoptively co-transferred recipients (Figure 8A). In the presence of 
rapamycin, both adult and neonatal CD8+ T cells became less terminal differentiated 
with smaller amount of SLECs than the control groups (Figure 8B). Next, we sought to 
examine whether limiting mTOR activity improved neonatal cell survival post-infection. 
We enumerated the cell numbers of all groups at during the resting memory stage on 25 
dpi. We found that limiting mTOR activity significantly increased the numbers of 
neonatal memory CD8+ T cells on 25 dpi, which suggest that control neonatal CD8+ T 
cells fail to form memory because of an excessive amount of mTOR activity (Figure 8C).  
To understand how mTOR alters neonatal CD8+ T cell metabolism, we sorted 
neonatal CD8+ T cells treated with PBS and rapamycin from infected recipient animals 
on 7 dpi and measured their glycolytic and OXPHOS activities. In the presence of 
rapamycin, neonatal CD8+ T cells displayed higher OXPHOS with higher basal and 
maximal OCR measurements (Figure 8D and 8E). Limiting mTOR activity also improved 
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memory forming potential in neonatal CD8+ T cells indicated by higher SRC, which 
indirectly validate that rapamycin treated neonatal CD8+ T cells gained more memory 
forming potential (Figure 8E). In addition, the catabolic glycolytic pathway also 
decreased in the presence of rapamycin (Figure 8F and 8G). Neonatal CD8+ T cells 
responding in the presence of rapamycin showed lower basal and maximal ECAR 
compared to the control group (Figure 8G). These data indicate that when mTOR 
activity is limited, neonatal CD8+ T cells engage in less glycolysis and more OXPHOS, 
which likely explains why neonatal effector CD8+ T cells become less terminally 
differentiated and are more capable of transitioning into the memory pool.   
In all of our studies up to this point, rapamycin was administered after infection.  
Thus, we wondered whether we could enhance neonatal memory CD8+ T cell formation 
by limiting mTOR in neonatal CD8+ T cells prior to antigenic stimulation.  To test this, 
we gave daily injections of either PBS or rapamycin to 7-day-old gBT-I donor mice for 3 
days and then harvested their CD8+ T cells to examine their responses to infection 
following adoptive transfer into congenic recipients. (Figure 9A). Interestingly, CD8+ T 
cells from neonatal gBT-I mice exposed to rapamycin exhibited a less memory like 
phenotype prior to infection, when compared to their counterparts exposed to PBS. 
(Figure 9B). As mTOR has been shown to be positively correlated with CD44 and 
CD122 expression in NK and T cells26–28,  it is possible that the reduced expression of 
these markers indicate that rapamycin was able to access CD8+ T cells in neonates 
and modify them. To test whether pre-treatment with rapamycin alters the fate of 
neonatal CD8+ T cells after infection, we next purified and adoptively co-transferred 
both PBS and rapamycin treated donor CD8+ T cells into recipients and examined their 
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response to infection in vivo. Rapamycin treated neonatal CD8+ T cells surprisingly did 
not exhibit a markedly different phenotype after infection. Indeed, both the PBS and 
rapamycin-treated groups displayed a similar amount of SLECs at the peak of the 
responses, suggesting that limiting mTOR activities in neonatal CD8+ T cells prior to 
stimulation is insufficient in altering their response to infection (Figure 9C). To validate 
this, cell numbers of WT and rapamycin treated neonatal CD8+ T cells were also 
evaluated on 7 and 14 dpi. There were no significant changes in cell numbers between 
the the PBS and rapamycin treated groups on 7 and 14 dpi, which further confirm that 
treating neonatal CD8+ T cells prior to infection does not change their ability to respond 
to intracellular pathogens (Figure 9D). These data suggest mTOR must be present 
during the activation and expansion phase of the response to alter the neonatal CD8+ T 
cells response to infection.  
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Figure 3.9. Rapamycin requires infection to improve neonatal CD8+ T cells survival. (A) 
Experimental design: daily rapamycin (100 ng/g) or PBS was given to 7-day-old neonates I.P. 
for 3 days prior to infection, splenic neonatal CD8+ T cells from each group was collected. (B) 
Phenotype (CD44 and CD122) of WT adult, WT neonatal and neonatal with rapamycin CD8+ T 
cells prior to infection. (C) SLEC population of WT neonatal and neonatal with rapamycin CD8+ 
T cells post-LmgB-infection on 7 dpi. (D) Cell number of WT neonatal and neonatal with 
rapamycin CD8+ T cells post-LmgB-infection on 7 dpi and 14 dpi.  
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DISCUSSION 
Extensive studies have shown that immune system does not develop from early 
life into adulthood in a linear fashion29–32. Instead, the immune system is formed from 
distinct developmental layers throughout life29–32. Metabolic programs have been shown 
to play critical roles in regulating T cell activation and differentiation in adulthood4,5,14. 
This report demonstrated many age-related differences in the CD8+ T cell response to 
infection is due to the utilization of different metabolic programs by CD8+ T cells at 
different stages of life.  
We previously found that neonatal mice have a significantly higher percentage of 
memory phenotype (CD44+CD122+) cells than their adult counterparts1. However, this 
phenotypic differences on the population levels does not explain why neonatal cells 
preferentially become short-lived effectors and are impaired at forming memory cells1. 
However, the larger percentage of memory phenotype cells in early life could contribute 
to the higher mitochondrial but lower glycolytic activities in naïve neonatal CD8+ T cells 
we found in this report. Since IL15 promote mitochondrial biogenesis, having larger 
composition of CD122+ (IL15 receptors) cells could grant naïve neonatal CD8+ T cells 
higher capacity to carry out mitochondrial activity10. It has been shown that memory 
phenotype cells are capable of proliferate faster and expand better than naïve CD8+ T 
cells upon activation33, which fits what we observed in neonatal CD8+ T cells. Future 
studies examining responses to infection in CD8+ T cells with different amount of 
OXPHOS activities (ex. with mitochondrial inhibitors) are needed to verify this 
hypothesis.  
Glucose metabolism plays an important role in supporting both CD8+ and CD4+ 
  
 84 
T cell proliferation and effector function7,8,34,35. CD8+ T cells heavily depend on 
extracellular glucose level for proliferation upon activation. Their proliferation decrease 
significantly when glucose level is low36,37. Even though we did not compare glucose 
uptake efficiency between adult and neonatal CD8+ T cells, we found that neonatal 
CD8+ T cells upregulate glucose receptor Glut1 and quickly improve the usage of 
glycolysis upon activation. This could explain why neonatal CD8+ T cells are able to 
proliferate rapidly post-infection. Neonatal CD8+ T cells also have lower SRC, which 
suggest lower mitochondrial fatty acid oxidation (FAO) activity10. Since FAO is critical in 
CD8+ T cell memory formation, this indicates that neonatal CD8+ T cells have lower 
memory forming potential10. There is also evidence suggesting that increased SRC and 
the ability to utilize OXPHOS are not essential in memory formation, rather the amount 
of ATP produced by the metabolic pathways used34. Further studies comparing different 
aged CD8+ T cell responses when ATP productions are normalized are called for to 
disentangle this question. Since more active metabolic profile (low OXPHOS and high 
glycolytic activities) are correlated with terminal differentiation status38,39, we wanted to 
assess the metabolic programs used by different aged CD8+ SLECs (Figure 6). 
Consistent with the layered immune system model, mostly fetal-layer derived neonatal 
CD8+ SLECs still demonstrated lower OXPHOS and higher glycolysis than adult SLECs.  
There are other important metabolic pathways supporting and regulating CD8+ T 
cell activation and differentiation we did not assess in this report. In addition to 
OXPHOS and glycolysis, some other well-studied pathways include fatty acid oxidation, 
fatty acid synthesis, pentose phosphate and amino acid metabolism4,5. All these 
pathways are critical in creating building blocks and meeting the cellular upon 
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activation4,5. Future experiments measuring more comprehensive metabolic profiles in 
different aged CD8+ T cells are called for to learn more about metabolic programs 
contributing to their different behaviors.  
Lin28 is a developmental-regulated protein that is highly expressed in early life20. 
Lin28a and Lin28b are the 2 paralogs of Lin28. They share high sequence identity and 
have been mostly considered equivalent20. There is accumulative evidence showing 
that Lin28b regulates immune responses1,19,40,41. Lin28 can promote mTOR activity 
either through suppressing its well-studied microRNA target let7 or directly stabilizing 
the translation of several critical proteins involved in mTOR pathway15,24. mTOR has 
also been studied extensively and has been shown to play an important role in T cell 
differentiation12,13. mTOR activity has been shown to increase glucose uptake and 
promote glucose metabolism in mice15,24,25. Limiting mTOR activities with its inhibitor 
rapamycin has been shown to abolish the increased glucose uptake induced by 
overexpressing Lin2815. Limiting mTOR can also promote adult CD8+ T cell memory 
formation22. We sought to investigate whether Lin28b can regulate neonatal CD8+ T 
cells responses through mTOR in this report. We demonstrated that iLin28b adult CD8+ 
T cells behaved more similarly to neonatal CD8+ T cells, and limiting mTOR activities in 
iLin28b adult CD8+ T cells restrained their inherent propensity to differentiate into short-
lived effectors and rescued their memory formation. This data proved that Lin28b 
regulates CD8+ T cell responses at least partially through mTOR. Some further 
experiments directly measuring the mTOR activities and the metabolic programs in 
iLin28b adult CD8+ T cells are required to validate the relationship between Lin28b-
mTOR axis and cell metabolism.  
  
 86 
We also attempted to assess the role of mTOR activities in neonatal CD8+ T 
cells and how it regulates cell metabolism. We found that limiting mTOR activities in 
neonatal CD8+ T cells reduced their contraction and terminal differentiation level post-
infection. Limiting mTOR also reduced OXPHOS and improved glycolysis in neonatal 
CD8+ T cells compared with their WT counterparts. We have previously demonstrated 
that neonatal CD8+ T cells have high level of Lin28b expression1. This data imply that 
upon activation, neonatal Lin28b promotes mTOR activities, which then result in a more 
metabolic active profile. Nearly all of the previous studies performed with adult T cells 
used rapamycin to limit mTOR activities after infection11,22,23. In this report, we sought to 
examine whether the time of administration would change its impact on neonatal CD8+ 
T cells behaviors, and found that rapamycin requires active infection to have its impact 
on neonatal CD8+ T cells (Figure 9).  
In conclusion, our study demonstrates that many of the cell-intrinsic differences 
between neonatal and adult CD8+ T cells during infection are driven by age-related 
changes in the metabolism. We propose a model whereby higher levels of Lin28b in 
neonatal CD8+ T cells drives an excessive amount of mTOR and glycolysis, which 
enables them to respond rapidly to infection, albeit at the expense of forming memory.  
Further studies are required to validate this model. However, to our knowledge, this 
study is the first report to examine metabolic programs in neonatal CD8+ T cells after 
infection and raises the possibility that the formation of neonatal memory CD8+ T cells 
can be therapeutically enhanced by manipulating key metabolic pathways.   
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CHAPTER FOUR 
The neonatal environment alters the ability of CD8+ T cells to respond to infection  
SUMMARY 
CD8+ T cells from different aged mice have been shown to behave differently in 
response to infection. Neonatal CD8+ T cells proliferate rapidly and quickly become 
more terminal differentiated.  They also fail to form sufficient memory and respond 
poorly to secondary infections. Many of these age-related changes in the CD8+ T cell 
response are due to cell-intrinsic differences. Different progenitors at different 
developmental stages give rise to CD8+ T cells with distinct traits. However, the impact 
of extrinsic factors on different aged CD8+ T cells remains unclear. Neonates possess a 
more lymphopenic peripheral environment than adults, which is believed to impact T cell 
homeostasis. In this report, we sought to address how age-related differences in the 
environment influence the CD8+ T cell response to infection. We found that after 
“parking” adult donor CD8+ T cells in neonatal recipient mice for a week, they start to 
acquire the characteristics of a neonatal CD8+ T cell. For example, they became 
phenotypically similar to neonatal CD8+ T cells, proliferated more rapidly after 
stimulation and lost ther ability to differentiate into memory cells. We also obtained 
some data to suggest that ROS production from neonates might serve as a potential 
signaling molecule at mediating these differences. Collectively, these findings suggest 
that, in addition to intrinsic developmental differences, there are age-related differences 
in the environment, which also impact the CD8+ T cell response to infection. 
INTRODUCTION 
Previous studies have shown that adult and neonatal CD8+ T cells display 
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different characteristics and can respond differently to infection1–3. Neonatal CD8+ T 
cells are more proliferative and quickly become more terminal differentiated post-
infection. They also contract rapidly and fail to form sufficient memory cells to carry out 
efficient secondary response1–3. These discrepancies can be attributed to the intrinsic 
differences between different aged CD8+ T cells, which are largely due to their distinct 
progenitors throughout development3. However, whether extrinsic factors also 
contribute to age-related differences in CD8+ T cell responses remains an open 
question.  
Following thymic selection, neonatal and adult CD8+ T cells enter very different 
peripheral environments. In particular, neonatal mice are lymphopenic, which results in 
an increased exposure to homeostatic cytokines on a per cell basis and consequently 
elicits a greater amount of homeostatic proliferation (HP)4. Homeostatic proliferation 
does not require contact with foreign antigen. Instead, naïve cells are believed to 
undergo spontaneous proliferation following stimulation by self peptide:MHC complexes 
and cytokines, such as IL-7 and IL-154–6. While previous studies have demonstrated 
that the neonatal environmental supports lymphopenia-induced proliferation, it is 
currently not known whether these changes that occur prior to infection alter their ability 
to respond to intracellular pathogens5–7. Here, we addressed this question by ‘parking’ 
adult donor CD8+ T cells in neonatal recipients for one week and comparing their 
phenotype and function after infection.   
Interestingly, we found that neonatal-experienced adult CD8+ T cells acquire a 
phenotype mimicking neonatal CD8+ T cells, as exhibited by higher expression of 
markers (CD44, CD122) typically associated with memory cells. Both neonatal cells and 
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adult cells exposed to the neonatal environment contained significantly higher levels of 
reactive oxygen species (ROS), which could explain why these cells are able to mount a 
more rapid proliferative response after in vitro stimulation. Lastly, we found that adult 
CD8+ T cells parked in the neonatal environment exhibit an imbalance in effector and 
memory cell differentiation that is characteristic of neonatal cells.    
MATERIAL AND METHODS 
Mice 
B6-Ly5.2/Cr mice were purchased from Charles River Laboratories (Frederick, 
MD). TCR transgenic mice specific for the HSV-1 glycoprotein B498-505 peptide 
SSIEFARL8 (gBT-I mice) were provided by Janko Nikolich-Zugich (University of 
Arizona, Tucson, AZ) and crossed with Thy1.1 or C57BL/6 mice purchased from 
Jackson Laboratories (Bar Harbor, ME). Neonatal and adult gBT-I animals were used at 
6 to 8 days old and at 2 to 4 months old, respectively. Mice were housed under specific 
pathogen-free conditions at Cornell University College of Veterinary Medicine, 
accredited by the Assessment and Accreditation of Laboratory Animal Care.  
Antibodies and flow cytofluorimetric analysis  
Antibodies were purchased from eBioscience (San Diego, CA), Biolegend (San 
Diego, CA), Invitrogen (Carlsbad, CA), or BD Biosciences (Mountain View, CA). Flow 
cytofluorimetric data were acquired using DiVa software from an LSRII equipped with 4 
lasers (BD Biosciences). Analysis was performed with FlowJo (Tree Star, Ashland, OR).  
Adoptive transfer 
Microbeads (Miltenyi Biotec) enriched gBT-I splenic adult and neonatal 
experienced adult CD8+ cells were combined at a 1:1 ratio. Combined cells were 
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suspended at 2×105 cells per ml of PBS and 100 ul of cells was injected i.v. into adult 
B6-Ly5.2 recipient mice. The next day, recipient mice were infected with WT LM-gB 
(5×103 CFU, i.v.) and later challenged with WT LM-gB (5×104 CFU, i.v.), as described.2  
In vitro stimulation and proliferation 
CD8+ T cells were labeled with carboxyfluorescein diacetate succinimidyl ester 
(CFSE), as described2, and cells were stimulated with plate-bound anti-CD3 (5 mg/ml) 
and anti-CD28 (20 mg/ml).  
Mitotracker and ROS staining 
Splenic CD8+ T cells were stained with 50 nM mitotracker green (ThermoFisher, 
M7514) or 2 uM H2DCFDA (ThermoFisher, D399) for 30 minutes at 37oC and ran on 
flow cytometer non-fixed.  
Statistical analysis  
Statistical analysis was performed using Prism (GraphPad Software, Inc, La 
Jolla, CA). Error bars represent standard error of the mean. Significance was 
determined by Student t test. Significance is denoted as: *P < .05, **P <  .01, ***P <  
.001, and ****P < .0001.  
RESULTS 
Neonatal-experienced adult CD8+ T cells become more phenotypically and 
functionally similar to neonatal cells 
In order to access how the neonatal environment affects CD8+ T cell 
development and differentiation, we transferred 1X106 adult gBT-I CD8+ T cells into 7-
day-old gBT-I neonates and “parked” them for a week (Figure 1A). We first assessed 
their expression of the memory-phenotype markers CD44 and CD122 by flow 
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cytometry. Neonatal-experienced adult CD8+ T cells acquired a higher percentage of 
memory phenotype cells (Figure 1B). There are also other markers known to be 
upregulated with HP, such as Ly6C, chemokine receptor CXCR3 and integrin CD11a. 
Neonatal-experienced adult CD8+ T cells showed significantly higher expression of 
Ly6C, CXCR3 and CD11a than wild type (WT) adult CD8+ T cells (Figure 1C). These 
data suggest that adult CD8+ T cells undergo a significant amount of homeostatic 
proliferation in neonatal recipient mice.  
One of the hallmark features of neonatal CD8+ T cells is that they proliferate 
rapidly in response to activation. Thus, we next sought to test whether neonatal 
environment enables adult CD8+ T cells to respond more quickly to TCR stimulation. 
Adult and neonatal-experienced gBT-I adult CD8+ T cells were coated with proliferation 
dye CFSE and stimulated with plate-bound anti-CD3 and anti-CD28 antibodies. We 
found that neonatal-experienced adult gBT-I CD8+ T cells did indeed proliferate more 
than control adult CD8+ T cells after stimulation (Figure 1D), as evidenced by their 
increased dilution of CFSE dye. Overall, our data suggest that being in a neonatal 
environment can change both the phenotype and function of CD8+ T cells.  
Different aged animals have different level of reactive oxygen species (ROS) 
Next we wondered how the neonatal environment enhances the ability of adult 
CD8+ T cell to respond to in vitro stimulation. Previously, we found that different aged 
CD8+ T cells utilize different metabolic programs (discussed in Chapter 3). This led us 
to consider the possibility that homeostatic proliferation increases certain signaling 
molecules or metabolic products, which might contribute to the differences we observed 
in neonatal-experienced adult CD8+ T cells. In our liquid chromatography/tandem mass 
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spectrometry based metabolomics analysis from CD8+ T cells harvested from different 
animals, one of the intriguing differences we observed was their distinct oxidative stress 
level. Both naïve and activated neonatal CD8+ T cells displayed significantly higher 
GSSG:GSH ratios than adult CD8+ T cells (Figure 2A). Antioxidant enzyme glutathione 
(GSH) can scavenge ROS and get oxidized to form glutathione disulfide (GSSG). The 
GSSG to GSH ratio is therefore a useful indicator of the oxidative stress level in cells. 
The higher the value, the more oxidative stressed the cells are.  
 
Figure 4.1. Adult CD8+ T cells in neonatal environment acquire neonatal phenotype and 
become more proliferative. (A) Experimental design: adult CD8+ T cells were transferred into 
neonates. 7 days later, neonatal-experienced adult CD8+ T cells were harvested for testing. (B) 
Memory phenotype (CD44 and CD122) of adult and neonatal-experienced adult (A→N) CD8+ T 
cells. (C) Homeostatic proliferation markers on adult and neonatal-experienced adult CD8+ T 
cells. (D) Neonatal-experienced CD8+ T cell proliferated faster than control adult CD8+ T cells 2 
days post-activation. **P < .01 and ***P < .001.  
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Reactive oxygen species (ROS) have historically been viewed as a metabolic 
byproduct that can cause cellular damage and induce apoptosis8,9. However, recent 
studies suggest that ROS can also enhance cellular signaling transduction8,10. Thus, we 
wondered whether elevated levels of ROS might explain why neonatal CD8+ T cells 
respond more quickly to stimulation but also exhibit increased death during contraction.  
To test this possibility, we wanted to assess the ROS producing capacity of CD8+ T 
cells from different aged animals. Mitochondria are known as the major powerhouse 
and the primary site of ROS production in cells11. We therefore reasoned that the 
amount of mitochondria could be used as an indicator of ROS producing potential. To 
examine the mitochondrial content in different aged CD8+ T cells, we first measured the 
expression of mitochondrial transcription factor A (TFAM), since it has previously been 
shown to regulate mitochondrial biogenesis12. Neonatal CD8+ T cells displayed 
significantly higher levels of TFAM mRNA, which indicate that they have a bigger 
potential to contain higher mitochondrial content (Figure 2B).  
In order to directly measure mitochondrial mass, we stained cells with mitotracker 
green for their total mitochondrial content and confirmed that neonatal CD8+ T cells 
have higher mitochondrial content than their adult counterparts (Figure 2C). Since the 
neonatal environment is capable of affecting the phenotype of adult CD8+ T cells, we 
wanted to also test whether neonatal-experienced adult CD8+ T cells have higher 
mitochondrial mass that can result in higher ROS production. In fact, neonatal-
experienced adult gBT-I cells also showed higher mitochondrial mass compared with 
WT adult CD8+ T cells (Figure 2D).  
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Figure 4.2. Adult and neonatal CD8+ T cells processes different amount of mitochondrial 
and ROS. (A) Neonatal CD8+ T cells showed higher oxidized glutathione (GSSG) to glutathione 
(GSH) ratios than adult CD8+ T cells. (B) Neonatal CD8+ T cells showed higher level of TFAM 
at 15 min post-activation. (C) Neonatal CD8+ T cells showed bigger mitochondrial mass. (D) 
Neonatal-experienced adult CD8+ T cells showed higher mitochondrial mass. (E) Neonatal 
CD8+ T cells showed higher antioxidant enzyme catalase. (F) Both naïve and activated (15 min) 
neonatal CD8+ T cells showed higher hydrogen peroxide level. *P < .05. **P < .01, ***P < .001 
and ****P < .0001. 
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Another well-studied antioxidant enzyme is catalase. The level of catalase is also 
a good indicator of ROS activity in cells. To see if catalase expression was different in 
neonatal and adult CD8+ T cells, we measured its expression by qPCR and found that 
neonatal CD8+ T cells express significantly higher levels than adults (Figure 2E). Lastly, 
we also stained the cells with ROS dye H2DCFDA to directly assess the hydrogen 
peroxide in either naïve or activated (15 mins) CD8+ T cells from different aged animals 
(Figure 2F). Both naïve and activated neonatal CD8+ T cells contained higher levels of 
hydrogen peroxide than their adult counterparts (Figure 2F).  
Collectively, our data indicates that neonatal CD8+ T cells contain more ROS 
than adults, which could be a result of higher mitochondrial content in CD8+ T cells.  
The increase in mitochondrial mass may be a function of cells undergoing more 
homeostatic proliferation, as adult CD8+ T cells ‘parked’ in neonatal recipient mice also 
contain larger amounts of mitochondria. These findings raise the possibility that cells 
with more mitochondrial mass (neonates and neonatal-exposed adults) respond to 
stimulation with more rapid ROS production, which enhances signaling and activation.    
Neonatal-experienced adult CD8+ T cells respond differently to infection 
Given that we have shown that the neonatal environment can change how adult 
CD8+ T cells respond to stimulation in vitro, we next wanted to examine how the 
neonatal environment would alter the behavior of adult CD8+ T cells after infection in 
vivo. To test this, adult and neonatal-experienced adult donor CD8+ T cells were 
purified and co-transferred into congenic adult recipients, and then infected the next day 
with Listeria Monocytogenes-gB (Lm-gB) (Figure 3A).  
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Figure 4.3. Adult CD8+ T cells in neonatal environment respond similar to neonatal CD8+ 
T cells post-infection in vivo. (A) Experimental design: adult and neonatal-experienced adult 
were adoptively co-transferred into recipients, then infected them with Lm-gB and serial bled. 
(B) Kinetics of adult and neonatal-experienced adult CD8+ T cells, neonatal-experienced adult 
CD8+ T cells failed to form sufficient memory. (C) Ratio of adult vs. neonatal-experienced adult 
CD8+ T cells throughout infection. (D) Percentages of SLEC and MPEC in adult and neonatal-
experienced adult CD8+ T cells. **P < .01 and ****P < .0001.  
 
Interestingly, the neonatal-experienced adult gBT-I CD8+ T cells did not expand 
as well as WT adult gBT-I CD8+ T cells and failed to form sufficient memory response 
upon challenge (Figure 3B). This is similar what we previously observed in neonatal 
CD8+ T cells. The ratios of WT adult to neonatal-experienced adult gBT-I CD8+ T cells 
(A:A→N) throughout infection were bigger than the input ratio and peaked on 5 dpi, 
which suggest that neonatal-experienced adult CD8+ T cells contracted more than WT 
adult CD8+ T cells (Figure 3C). We also examined the phenotype of both groups of 
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donor cells at the peak of the response and found that the neonatal-experienced adult 
CD8+ T cells preferentially became short-lived effector cells (SLECs, CD127-KLRG1+) 
compared to WT adult CD8s (Figure 3D). Based on these results, we conclude that the 
neonatal environment is capable of changing how CD8+ T cells behave in response to 
infection and further exacerbates the imbalance in effector and memory cell 
differentiation in early life.  
DISCUSSION 
There are several possible extrinsic differences between the neonatal and adult 
peripheral environment. Neonates have peripheries with fewer immune cells and are 
therefore considered to be lymphopenic4. When mature neonatal CD8+ T cells leave the 
thymus and enter a periphery containing a low a number of T cells they undergo 
extensive HP and upregulate phenotypic markers associated with cell division13. In 
contrast, newly made CD8+ T cell entering an adult environment undergo significantly 
less homeostatic proliferation, because many more T cells occupy the peripheral 
environment. Lymphopenia-induced CD8+ T cells have undergone more rounds of 
proliferation and are known as “virtual memory” cells due to their memory phenotype14. 
Although they are still naïve cells in the sense that they have yet to encounter their 
cognate peptide, they respond differently than true naïve CD8+ T cells14,15. We found 
that neonatal-experienced adult CD8+ T cells upregulate HP related markers, indicating 
they have undergone more extensive HP.  
Another possible difference in the environment of neonatal and adult animals 
could relate to the amount cytokines that are present in the periphery. Presently, there 
have not yet been any reports performed to directly compare the amounts of specific 
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homeostatic cytokines between neonatal and adult animals. However, some studies 
have reported different cytokine profiles in different aged animals and humans16,17. For 
example, infants have higher level of IL-2 and IL-417. And aging mice tend to have 
gradually decreased level of IL-2 and IFNγ16. It is also well accepted that there are 
different amounts of DCs in neonatal and animals, which can produce different level of 
cytokines (e.g. IL-15) in extracellular environment18–20. In addition, the overall levels of 
metabolites (lactate, nucleotides, etc.) and cellular products (ROS, fatty acid, etc.) can 
also be different in neonates, which could participate in signaling pathway mediating 
CD8+ T cell behavior.  
Mitochondria serve a critical role in powering cellular functions and regulate 
cellular processes to meet the current demand. Several major metabolic pathways 
involved in T cell responses rely on proper mitochondrial function21–24. Mitochondria play 
an important role in mediating cellular metabolic programs to support CD8+ T cell 
activation and differentiation21–23. Mitochondria are also the major production site of the 
common cellular product ROS. In theory, bigger mitochondrial implies different amount 
of metabolites accumulated extracellularly. We attempted to address this by measuring 
mitochondrial content in different CD8+ T cells harvested from neonatal and adult 
animals. Our data indicate that neonatal CD8+ T cells indeed have more mitochondrial 
content than adult CD8+ T cells. Neonatal environment can also promote mitochondrial 
biogenesis in adult CD8+ T cells resulting in larger mitochondrial mass. One recent 
study suggest that mitochondria itself can also affect how CD8+ T cells respond in vitro 
stimulation25. Mitochondria tend to modify and become fused in memory CD8+ T cells. 
Fused mitochondria have also been shown to promote fatty acid oxidation to support 
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memory formation and improve their anti-tumor activities25. In the future it would be 
interesting to more formally link mitochondrial mass and structure in different aged 
CD8+ T cells with their ability to respond to microbial challenge.  
Our metabolomics data suggest that neonatal T cells are under a greater amount 
of oxidative stress, suggesting that there is higher ROS produced by neonatal cells. 
ROS are produced by the partial reduction of oxygen, which includes superoxide anion 
(O2-), hydrogen peroxide (H2O2), and hydroxyl radical (HO.). When the level of oxygen 
exceeds the cell’s ability to carry out an antioxidant response, the condition is known as 
oxidative stress8. ROS is generally known as a detrimental cellular byproduct to induce 
cell death. However, several studies have shown that ROS plays essential role in 
activating T cells and fine-tuning their responses21,26–28. Since ROS can transduce 
signals and induce apoptosis in T cells, we suspect that ROS could affect CD8+ T cell 
behaviors. We attempted to address this question starting examining ROS production in 
different aged CD8+ T cells. We found that neonatal CD8+ T cells can produce higher 
amount of ROS than adult CD8+ T cells. The conclusion that neonatal CD8+ T cells are 
under higher level of oxidative stress was supported by data indicating that they also 
exhibit higher GSSG:GSH ratios and amounts of the antioxidant enzyme catalase. 
Collectively, our data suggest that neonatal environment might alter adult CD8+ T cell 
response by promoting mitochondrial biogenesis, which result in more ROS production 
to facilitate signaling.  
An important question is how does ROS alter the function of CD8+ T cells? ROS 
has been shown to regulate cellular proliferation and survival by activating NFkB and 
NFAT1 in T cells, resulting in increased proliferation and differentiation. Additionally, 
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ROS can also activate other molecules, such as transcriptional factor AP1 and protein 
kinase C (PKC).  AP1 and PKC are both important in T cell activation and AP1 is also 
involved in inducing apoptosis9,29–33. One recent study has proved that ROS triggers 
GSH activities, which can drive metabolic pathways supporting effector T cell 
functions10. This might explain why neonatal-experienced CD8+ T cells proliferate 
rapidly and became more terminal differentiated post-infection. However, further studies 
directly investigating the specific role of ROS on regulating CD8+ T cells with different 
level of extracellular ROS (inhibitor or enhancer) are warranted to fully understand how 
ROS influences the CD8+ T cell response.  
Collectively, our findings indicate that neonatal environment is capable of altering 
adult CD8+ T cell responses, which further exacerbate the age-related changes due to 
cell intrinsic differences.  
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CHAPTER FIVE 
SUMMARY AND FUTURE DIRECTIONS 
General Background 
Neonates often generate incomplete immunity against intracellular pathogens. As 
CD8+ T cells are essential for clearing intracellular pathogens, it is crucial to understand 
why they behave differently than adults during infection. The long-standing belief is that 
neonates have impaired immunes systems, which make them more prone to repeated 
infections. Surprisingly, we discovered that neonatal CD8+ T cells are more susceptible 
to infection because they quickly become terminal differentiated and fail for form 
sufficient immunological memory1. Other researchers also found that neonatal CD4+ T 
cells develop a hypersensitive Th2 skewed response2. These findings suggest that 
neonates are more susceptible to infections not because they have immature immune 
systems, rather because their immune cells respond differently to infections early in life.  
The underlying mechanisms contributing to the discrepancies between adult and 
neonatal CD8+ T cells are still unclear. Both intrinsic and extrinsic factors could impact 
different aged CD8+ T cells behaviors. In this thesis, I focused on understanding what 
factors are contributing to the different responses carried out by neonatal CD8 T cells.  
Summarized Findings 
I started by investigating intrinsic differences. In chapter 2, using T cell receptor 
transgenic mouse model, I showed that progenitors from different aged animals give 
rise to unique CD8+ T cells in the periphery. My findings are consistent with the current 
“layered immune system” model, which theorizes that cells of the immune system seed 
the periphery in distinct waves of cells throughout development3–5. Instead of 
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progressing in a linear fashion, the immune system is composed of multiple distinct 
waves of cells throughout development. This model challenges the common belief that 
neonatal immune cells are just underdeveloped immune cells. The finding that they in 
fact come from distinct lineages will be critical in development age-targeted 
immunotherapies. Effective treatments may need to involve new classes of drugs, and 
not simply adjusting the dosage of the adult medications for neonates.  
 
Figure 5.1. Overview of chapters.  
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Additionally, I provided evidence that a developmental-regulated RNA binding 
protein Lin28b could potentially regulate neonatal CD8+ T cell development. Lin28b is 
highly conserved across species ranging from Drosophila to human6. While human 
studies are relevant, they are generally limited to examining peripheral blood, in contrast 
to the in-depth analysis of our murine infection model allows. The role of Lin28b in 
regulating homeostasis is not a new concept. Other researchers have shown that 
Lin28b supports fetal-like lymphopoiesis in adult HSCs, resulting in increased 
productions of fetal B cells, natural killer T cells, regulatory T cells and ɣδT cells7–9. 
However, to our knowledge, our publication is the first report showing how Lin28b 
mediates neonatal-like responses to infection in CD8+ T cells.  
In Chapter 3, I extended my cell intrinsic studies of different aged CD8+ T cells to 
better understand the underlying mechanisms that contribute to age-related different 
responses. Recently, T cell metabolism has drawn a lot of attention, due to its promising 
role in immunotherapy10. Cellular metabolism is essential in supporting cellular function 
and ensuring proper differentiation of cells. Dysregulation in cellular metabolism is 
known to lead to detrimental outcomes (e.g. cancer). Researchers have found key 
metabolic regulators that are deterministic of cell fate11,12. Since CD8+ T cells of 
developmental origin adopt different fates, I asked whether the metabolic profiles in 
different aged CD8+ T cells are also different. I found that neonatal CD8+ T cells 
acquire a more metabolic active profile (lower OXPHOS and higher glycolytic activities) 
compared to adult CD8+ T cells post-infection. This is consistent with studies 
demonstrating that effector T cells upregulate catabolic pathways to support their rapid 
proliferation, and a more quiescent metabolic program is required to sustain naïve T 
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cells and form memory T cells11–14. I also demonstrated that terminally differentiated 
CD8+ T cells from adult and neonates displayed different metabolic programs, 
suggesting that the discrepancies I observed are largely due to intrinsic properties, 
lending further support to the idea that there are developmentally distinct layers of CD8+ 
T cells.   
I also found that by limiting mTOR activities with rapamycin, I reshaped the 
metabolic programs and improved the survival of neonatal CD8+ T cells. In the 
presence of rapamycin, neonatal CD8+ T cells acquired a more quiescent metabolic 
program (less glycolytic and more OXPHOS) compared with WT neonatal CD8+ T cells, 
which suggest that mTOR is important in regulating cellular metabolism neonatal CD8+ 
T cells. Rapamycin also rescued memory formation in iLin28b adult CD8+ T cells, 
indicating that Lin28b could elicit its effect via mTOR pathway.  
My findings from Chapter 2 and 3 have successfully established the significance 
of intrinsic differences between adult and neonatal CD8+ T cells. How, it is likely that 
extrinsic factors also contribute to developmentally related differences in CD8+ T cell 
responses. In Chapter 4, I showed that neonatal environment is capable of modifying 
the phenotype and response of adult CD8+ T cells. It is not surprising that lymphopenic 
neonatal environment promote proliferation in adult CD8+ T cells since there is 
evidence showing lymphopenia can induce homeostatic proliferation15. However, it is 
intriguing to learn that the neonatal environment can change adult CD8+ T cell 
behaviors in response to infection in vivo. Neonatal environment also promoted 
mitochondrial biogenesis in adult CD8+ T cells, which could potential results in higher 
ROS production to mediate signaling. My findings suggest that extrinsic factors can 
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exacerbate the aged-related differences induced by cell-intrinsic properties.  
Future Directions and Discussion  
This thesis focused on post-thymic distinctions in different aged CD8+ T cells. 
However, thymic environment plays an important role in shaping CD8+ T cell responses. 
My intra-thymic transfer experiment (chapter 2) suggests that different aged progenitors 
give rise to unique cell populations within the same thymic environment. However, 
future experiments to directly examining the differences in thymic environment (cytokine 
level, progenitor sensitivity towards cytokines, etc) will be important for a more complete 
understanding of the effects of thymic environment on CD8+ T cell behaviors.   
Although the layered immune system model is well characterized, how distinct 
developmental layers throughout life contributing to responses to infection are still 
perplexing. Fate-mapping experiments are needed to learn how these layers persist in 
life and how they could participate in combating infections. Current fate-mapping study 
in the lab suggests that CD8+ T cells made early in life proliferate more rapidly and are 
more sensitive to pro-inflammatory cytokine IL-12/IL-18 than cells made in older animals. 
CD8+ T cell made early in life also preferentially differentiate into SLECs during 
infection in adulthood. These data suggest that CD8+ T cell responses after infection 
are influenced by when the responding cells were made.  
It will also be interesting to further investigate how Lin28b is involved in neonatal 
CD8+ T cell development. Moreover, it will be important to determine if it is necessary or 
if there maybe are other compensating pathways. Experiments investigating neonatal 
cells behavior without Lin28b at different development stages (fetal vs. neonatal) would 
help answering these questions. Since Lin28b is a RNA binding protein, sequencing 
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experiments comparing RNA profiles in neonatal CD8+ T cells with different level of 
Lin28b may assist in the identification of its potential targets.  
I showed that rapamycin treatment dampens the metabolic programs in neonatal 
CD8+ T cells. In the future, it will be important to design experiments directly measuring 
mTOR activities in different aged CD8+ T cells. My data sheds light on how metabolic 
programs differ between adult and neonatal CD8+ T cells, and provide evidence that 
metabolic pathways could serve as potential drug targets in neonates. The metabolic 
profiles in different aged CD8+ T cells will be required to design optimal therapies in 
neonates.  
Cellular metabolism is very complex and intertwined; it is unlikely that only one or 
two pathways direct cellular functions. In this thesis, I focused on 2 major pathways: 
OXPHOS and glycolysis. However, there are evidences showing that other metabolic 
pathways (ex. fatty acid oxidation, amino acid metabolism, pentose phosphate, etc.) are 
also involved in T cell activation and differentiation11,13. Therefore, future studies 
focusing on other metabolic pathways are required to reveal a comprehensive picture of 
neonatal metabolic profile. It will also be important to study when metabolic programs 
diverge in different aged CD8+ T cells. For example, they could be different at 
progenitor level or gain the differences in the peripheral post thymic maturation. To 
address these possibilities, a fate-mapping strategy would be useful. Investigating 
metabolic programs at different time (progenitors, recent thymic emigrants and mature T 
cells) and tracing experiments would be essential to answer this question.  
ROS has long been classified as detrimental byproducts produced by cells, but 
recently, more functional roles have been assigned to ROS16,17. My data showed that 
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neonatal and neonatal-experienced adult CD8+ T cells both contain higher 
mitochondrial content, which might result in more ROS production. ROS production 
needs to be measured in neonatal-experienced adult CD8+ T cells. Manipulating ROS 
level in different aged CD8+ T cells is also critical in defining the functional role of ROS 
in shaping T cell responses. Amount of mitochondrial can also be regulated to 
investigate its relationship with ROS production.  
My findings clearly showed that neonatal CD8+ T cells do not generate sufficient 
memory cells due to the intrinsic differences between neonatal and adult CD8+ T cells. 
It would also be interesting to investigate whether neonatal CD8+ T cell generate similar 
or different type of memory cells compared with adult CD8+ T cells. By definition, 
central memory T cells express CCR7 and CD62L, whereas effector memory T cells 
lack both markers but have higher Tbet level18. Since neonatal CD8+ T cells express 
lower CD62L and higher Tbet following infection compared with adult CD8+ T cells, it 
would be more likely that when neonates generate memory cells, they would 
preferentially generate effector memory T cells. Further experiments assessing the traits 
of memory cells generated by adult and neonatal CD8+ T cells are needed to address 
this question further.  
There is evidence in the field suggesting that neonatal CD4+ respond differently 
(Th2 biased) compared with adult CD4+ T cells2. However, there is no directly 
comparison of CD4+ T cell progenies derived from different aged progenitors. My intra-
thymic progenitor transfer experiment can be used to investigate whether different aged 
progenitors could give rise to distinct CD4+ T cells in the periphery. In this experiment 
set-up, in order to examine intrinsic differences between fetal and adult progenitors, 
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different aged progenitors are allowed to develop in the same thymic environment. 
Assessing the responses of different progenitor-derived CD4+ T cells to infection will 
allow us to conclude whether ontogeny of CD4+ T cells supports the layered immune 
system hypothesis.  
There is also a large body of studies investigating metabolism in adult CD4+ T 
cells13. Th1, Th2 and Th17 effector cells preferentially use glycolysis, and Treg and 
memory T cells utilize more quiescent metabolic program, such as FAO13. 
Nevertheless, there is very limited knowledge on metabolism in neonatal CD4+ T cells. 
My findings suggest that different aged CD8+ T cells utilize different metabolic 
programs. It would be interesting to examine whether different metabolic programs 
underlie the differences between different aged CD4+ T cells by directly measuring their 
usage of different metabolic pathways following activation.  
Infections can be quite complex, and cells respond differently depending on the 
specific type of infection. I only assessed neonatal CD8+ T cells response to acute 
systemic infections (Listeria-gB and vaccinia-gB) where they respond vigorously at the 
expense of memory formation. However, I have not investigated tissue specific 
infections (e.g. respiratory infection) or chronic infections (e.g. CMV).  
Young children endure more severe symptoms from respiratory infections, in part 
due to their reduced tissue resident memory CD8+ T cells19. Neonatal mice are still able 
to produce effector CD8+ T cells in response to influenza infection19. However, the 
amount of neonatal lung resident memory CD8+ T cells is drastically reduced compared 
with adults19. Similar to our observations about neonatal effector T cells in response to 
acute systemic infection, effector cells generated after influenza infection in neonates 
  
 116 
are also more terminal differentiated19. In addition to that, CDC (Centers for Disease 
Control and Prevention) do not recommend flu vaccines for children under 6 months 
old, which renders limited ways to protect infants from influenza infection. My findings 
suggest that development-regulated RNA binding protein Lin28 and metabolic programs 
are critical in regulating CD8+ T cell differentiation. Tempering Lin28 targeted pathways 
and/or metabolic programs can potentially promote better memory formation in CD8+ T 
cells to help protecting infants against early influenza infection. Manipulating Lin28 
targeted pathways and T cell metabolism can also serve as adjuvants to maximize the 
protective effects from flu vaccines in young children (6 months – 5 years old).   
Cytomegalovirus (CMV) is a chronic infection known to cause serious problems in 
fetuses and immune-compromised adults.20,21 One hallmark about CMV infection is that 
there is a large amount of CMV specific memory cells in adulthood from infection 
acquired in early life, known as memory inflation.20,21 Studies have found that fetuses 
are able to produce effector CD8+ T cells early in life and neonatal CD8+ T cell 
repertoire diversified after CMV infection20–22. However, the significance and persistence 
of the contribution from these effector T cells produced early in life have not been 
studied in details. My findings demonstrated that fetal-driven CD8+ T cells become 
highly differentiated. One would suspect that their contributions to the persisted CMV 
specific memory cell pool later in life might be limited. Fate-mapping experiments during 
CMV infections would help us to understand the role of fetal-driven CD8+ T cells in 
adulthood.  
Chronic infections are also known to cause T cell exhaustion with impaired T cell 
functions23. Recent therapies targeting exhaustion marker PD-1 have shown promising 
  
 117 
clinical effects in tumor treatments, which suggest that phenotypically exhausted T cells 
might play a functional role in diseases23. It would also be interesting to know how 
neonatal CD8+ T cells would behave in response to chronic infection. My findings 
suggest that neonatal CD8+ T cells contract a lot faster than their adult counterparts 
and are more responsive to similar level of stimuli. One can predict that there might not 
be an observable population of exhausted neonatal CD8+ T cells following chronic 
infection due to their rapid contraction rate, which could result in limited effectiveness of 
current PD-1 therapies in neonates. Examining neonatal CD8+ T cell responses in 
chronic infection and cancer models directly will help addressing this question.  
Conclusions 
Overall, this thesis demonstrated that fetal and adult progenitors give rise to CD8+ 
T cells with unique behaviors at different developmental stages, and distinctive 
metabolic programs utilized by different aged CD8+ T cells could underlie their 
responses to infection. In addition to the drastic intrinsic differences, extrinsic factors in 
the periphery of different aged animals might also provide a minor but significant 
contribution to their different behaviors. My findings advance the understanding of 
different aged CD8+ T cells, and cast light on identifying potential therapeutic targets in 
neonates.  
From an evolutionary perspective, species are constantly undergoing natural 
selection to become better adapted in order to survive and reproduce.  Insufficient 
memory formation in neonatal CD8+ T cells may not be a “defective” response. 
Neonatal immunity could have been shaped by natural selection to devote limited 
resources towards a vigorous primary response to combat the infections during this 
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more susceptible period. The trade-off is that they will not form long-lived memory cells. 
Later in life, selective pressure may have driven adult CD8+ T cell response towards the 
production of long-lived memory cells to improve their longevity.   
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